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Ebselen (Ebs) is considered as a glutathione peroxidase (GPx) mimetic and primarily 
thought to function by scavenging intracellular reactive oxygen species (ROS).  Previous 
to our work, Deng et al. (2010a) demonstrated complete block of ICl,swell with 15 M Ebs 
following endothelin-1 (ET-1) induced activation of the current in cardiomyocytes.  This 
block was presumed to take effect mainly via the quenching of ROS.  Nonetheless, our 
work with DI TNC1 astrocytes strongly emphasizes that Ebs might function by an 
alternative mechanism based on its kinetic profile in blocking ICl,swell.  Our experiments 
showed that 45 nM Ebs can fully block ICl,swell thus suggesting an apparent IC50 <5 nM.  
Based on this result, we predicted Ebs to possess a high kon with a low koff close to zero.  
As predicted, Ebs failed to washout in the timescale covered by our patch-clamp 
experiments.  The block was also distal to H2O2, previously considered as the most 
proximate regulator of ICl,swell.  And based on further evidence demonstrating irreversible 
block of ICl,swell distal to H2O2 with Ebs congeners, complete suppression of native ICl,swell 
with MTS reagents, and failure of Ebs to block ICl,swell from the cytosol, we concluded that 
Ebs and its congeners can covalently modify important –SH groups required for current 
activation while functioning as sulfhydryl reagents.  Complete irreversible block of ICl,swell 
with 110 M cell impermeant MTSES in native DI TNC1 astrocytes contrasts sharply to 
SWELL1 (Qiu et al., 2014) or LRRC8A (Voss et al., 2014), the latest molecular entity 
presumably responsible for ICl,swell, where 3.33 mM MTSES failed to demonstrate block 
of ICl,swell in the wild-type stably expressing SWELL1 (Qiu et al., 2014).  Our data with 
Ebs, its congeners, and MTS reagents indicate the existence of a common extracellular 
binding site which involves a selenenylsulfide (Se-S) bond that critically modulates 
ICl,swell.  We, therefore, synthesized a derivative of Ebs called ebselen-para-yne (Ebs-p-
yne), which provided an even higher affinity for blocking ICl,swell with a presumed IC50 
~picomolar range.  Ebs-p-yne is a promising novel molecule that may serve as a tag in 
identifying the molecular fingerprint ultimately responsible for ICl,swell.  Furthermore, we 
can take advantage of click chemistry to ultimately pull out the channel or channel 
xx 
 
component which has remained elusive for greater than two decades. 
 
 
 
 
 
CHAPTER 1 
INTRODUCTION  
2 
 
1.1  Origin of ICl,swell and Phenotypic Expression 
Several years after pioneering experiments studying the effects of electrogenic 
mobility of radiolabeled cations and anions due to cell volume changes in Ehrlich ascite 
tumor cell line and human lymphocytes (Grinstein et al., 1982; Hoffman, 1978; Hoffman 
et al., 1984; Sarkadi et al., 1984 a and b), two groups used electrophysiological 
techniques to independently record the volume-sensitive Cl- currents in epithelial 407 
cells and human lymphocytes for the first time (Hazama and Okada, 1988; Cahalan and 
Lewis, 1988).  This current is now referred to as the swelling-activated chloride current 
(ICl,swell) and is also known as the volume-activated chloride channel (ICl,vol), volume-
regulated anion channel (VRAC), volume-sensitive organic osmolyte anion channel 
(VSOAC), or volume-sensitive outwardly rectifying (VSOR) Cl- channel.  These names 
refer to the same current or ‘entity’ and arise from various research contributions.  
Henceforth we will refer to it as ICl,swell.  ICl,swell turns on in response to cell swelling and 
various stimuli and plays a crucial role in regulatory volume decrease, electrical activity 
in heart, programmed cell death, and even ischemic preconditioning (Baumgarten et al., 
2005).  ICl,swell also responds to stretch and has shown important relevance in mechano-
sensitive signaling (Baumgarten and Clemo, 2003).      
  ICl,swell is ubiquitously expressed in diverse tissues across multiple species, 
including man.  For example, a few years after its initial description, ICl,swell was identified  
in freshly isolated adult canine cardiac myocytes (Tseng, 1991 and 1992).  It plays critical 
roles in mouse and human cholangiocytes or bile duct epithelial cells where cell volume 
regulation is vital to survival (Chen et al., 2010), nasopharyngeal carcinoma cells (CNE-
2Z) where channel expression is highest during G1 phase and is lowest at S phase with 
subsequent increase in M phase (Chen et al., 2002), fibroblasts derived from periodontal 
ligament in humans (Chung and Kim, 2002), trout red blood cells (Egee et al., 1997), rat 
articular chondrocytes (Ponce et al., 2012), endothelial cells from bovine pulmonary artery 
(Szucs et al., 1996), interstitial cells of Cajal (Park et al., 2005), pancreatic duct cells 
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(Verdon et al., 1995), and glial cellls in the brain (Mongin, 2015).  Even though broadly 
distributed among various tissue, the molecular identity or the genetic signature of the 
channel has been elusive and several claims have been overturned (Baumgarten and 
Clemo, 2003; Baumgarten et al., 2005).  Aspects of the current elicited by hypotonic 
challenge are tissue specfic, and one cannot exclude the possibility that distinct proteins 
or multiple channel isoforms contribute to the current empirically identified as ICl,swell.  
Most recently, a protein refered to as SWELL1 (Qiu et al., 2014) or LRRC8A (Voss et al., 
2014) was putatively identified as the basis for ICl,swell by two groups.  
  
 
1.2  Biophysical Characteristics and Physiological Relevance of ICl,swell 
Some of the features of ICl,swell differ in comparison to other Cl- currents.  ICl,swell 
displays outwardly-rectifying Cl- current or inward Cl- ion flux upon stepping to postive 
potentials in both physiological and symmetrical Cl- gradients.  Outward-rectification in 
symmetrical Cl- gradient is only observed in ICl,swell, whereas other Cl- channels display 
a linear current-voltage relationship in symmetrical Cl- solutions.  ICl,swell displays time-
independent behavior over most of the physiologic voltage range with partial inactivation 
as voltage steps toward more positive potentials and reverses at the Cl- equilibrium 
potential (ECl) predicted by the Nernst Equation.  Nevertheless, multiple anions permeate 
through the channel following the permeability sequence SCN- > I-  NO3
- > Br- > Cl- > 
Asp-, a low-field strength anion selectivity resulting with an Eisenman type I sequence 
(Mongin, 2015).  Moreover, the selectivity between anions is relatively modest.  
Studies show that ICl,swell observed in normal mammalian cardiac myocytes is 
independent of Na+, K+, or Ca2+ ions since replacing these cations with non-permeant 
cations fails to dissipate the current, and ICl,swell is recorded in the presence of the 
intracellular Ca2+ chelator EGTA or BAPTA (Baumgarten and Clemo, 2003; Baumgarten 
et al., 2005); nonetheless, diseased embryonic chick myocytes do show intracellular Ca2+ 
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dependency blockable by removing Ca2+ from bath solution (Hall et al., 1997).  Others 
suggest that Ca2+-nanodomains may be critical for proper activation of this current (Akita 
et al., 2011).  ICl,swell persistently activates under iso-osmotic conditions in hypertrophic 
ventricular myocytes freshly isolated from dogs with tachycardia-induced 
cardiomyopathy.  In turn, exposing these diseased myocytes to osmotic swelling fails to 
further increase the current, and osmotic shrinkage blocks the current compared to non-
diseased canine cardiomyocytes where ICl,swell only activates following osmotic challenge 
(Clemo et al., 1999).   
One of the first electrophysiological recordings of ICl,swell in the brain comes from 
an astrogliomal C6 cell line that accumulates inositol during chronic hypertonic stress.  
Upon cell swelling, whole-cell conductance increases rapidly to 1.5-2 nS/pF and displays 
an outwardly-rectifying anion selectivity with enhanced inositol and taurine efflux.  Further 
investigations show that certain organic osmolytes efflux through ICl,swell (Jackson and 
Strange, 1993) altering neuronal output and release astrocytic signaling molecules or 
gliotransmitters for active neuron-astrocyte communication (Haydon and Carmignoto, 
2006; Parpura et al., 2012).  There is also evidence supporting the role of increased Cl- 
conductivity through ICl,swell accompanying a shift in membrane potential (EM) in cases of 
mild, moderate to severe traumatic brain injury (TBI) when K+ ions elevate extracellularly 
reseting the K+ ion equilibrium potential (EK).  In turn EM shifts to a value between ECl 
and EK.  The establishment of this new electromotive driving force now favors both K
+ 
influx accompanied by Cl- influx through ICl,swell. The resulting net influx of KCl follows 
electroneutrality and is accompanied by an osmotic water movement into the cells. 
 
     
1.3  Pharmacology of ICl,swell 
Initial studies of ICl,swell utilized anion channel blockers that were not selective.  For 
example, members of the stilbene family such as DIDS (4,4′-diisothiocyanotostilbene-
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2,2′-disulfonic acid), DNDS (4,4′-dinitrostilbene-2,2′-disulfonic acid) and SITS (4-
acetamido-4′-isothiocyanostilbene-2,2′-disulfonic acid) were found to block the anion 
current evoked by swelling.  In canine cardiomyocytes taken from the atria (Sorota, 1994) 
and primary astrocyte cell culture taken from Sprague-Dawley rats (Parkerson and 
Sontheimer, 2004), the block of ICl,swell with DIDS demonstrates voltage-dependence with 
greater inhibition of the outwardly-rectifying current than the inward current.  Block by 
DNDS and SITS are also voltage-dependent (Sorota, 1994; Hagiwara et al., 1992; Shuba 
et al., 1996).  DIDS does not block ICl,PKA, an isoprenaline-activated protein kinase A 
(PKA)-dependent-Cl-current (Hume et al., 2000; Jentsch et al., 2002), a chloride current 
often confused with ICl,swell.  DIDS, however, is a potent blocker of ICl,Ca (Ca2+-activated 
Cl- channel), monovalent cation and ATP-dependent K+ channel (KATP), and Na
+- and 
Cl--dependent bicarbonate transporters (Baumgarten and Clemo, 2003).  In addition to 
stilbene derivatives, Sorota (1994) lists several other compounds that are tested in canine 
atrial cardiomyocytes for pharmacological activity: niflumic acid, NPPB (5-nitro-2-(3-
phenylpropylamino) benzoic acid, IAA-94 (indanyloxyacetic acid-94), 9AC (9-anthracene 
carboxylic acid), dideoxyforskolin, and extracellular cAMP.  Under whole cell patch-clamp 
condition after demonstrating Cl- ion selectivity and Ca2+ ion independence, niflumic acid, 
NPPB, and IAA-94 are identified as full blockers of ICl,swell in canine heart cells with off-
target effects on cation channels at the same concentration used to block ICl,swell whereas 
9AC, dideoxyforskolin, and extracellular cAMP are characterized as partial blockers of 
ICl,swell providing 50%, 80%, and 10% inhibition, respectively (Sorota, 1994).  In 
comparison to DIDS, DNDS, and SITS, niflumic acid and NPPB inhibit the channel in a 
voltage-independent manner (Parkenson and Sontheimer, 2004).  Using both 
hippocampal astrocytes from neonatal rats and astrocyte cultures with gap junction 
protein (Cx43) knockout genetically modified in mice, Ye et al. (2009) also provides 
important pharmacology of NPPB, IAA-94, and tamoxifen discussing the relative cross-
inhibition of Cx43, referred sometimes as connexin hemichannels, and ICl,swell.  Finally 
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DPC (diphenylamine-2-carboxylic acid) inhibits ICl,swell in embryonic chick myocytes 
(Zhang et al., 1993), glibenclamide (antidiabetic drug and KATP channel blocker) blocks 
both ICl,swell and ICl,PKA in cardiomyocytes (Sakaguchi et al., 1997; Yamazaki and Hume, 
1997), genistein (protein tyrosine kinase inhibitor) suppresses both ICl,swell and stretch-
activated Cl- current in heart (Browe and Baumgarten, 2003), and PP2 (selective blocker 
of focal adhesion kinase (FAK) and Src (proto-oncogene c-Src) fully inhibits the stretch-
activated Cl- current, which most likely is due to ICl,swell (Browe and Baumgarten, 2003).  
A higher affinity blocker of ICl,swell with improved selectivity between anion 
channels is tamoxifen, an estrogen receptor antagonist utilized clinically in the treatment 
of breast carcinoma (Kistner and Smith, 1960; Herbst et al., 1964; Cole et al., 1971; Ward, 
1973).  Tamoxifen provides complete block of ICl,swell at 10 µM in cardiac tissue 
(Vandenberg et al., 1994; Duan et al., 1997) and does not block ICl,PKA or any of the 
inwardly-rectifying Cl- channels.  On the other hand, off-target effects of tamoxifen include 
block of the ligand-gated cation channels, L- and T- type Ca2+ channels, the big 
conductance BK K+ channels, IKs or the delayed rectifier, tetrodotoxin (TTX)-sensitive 
Na+ channels, and cardiac gap junction proteins in multiple preparations (Vandenberg et 
al., 1994; Duan et al., 2000; Allen et al., 1998; Dick et al., 1999 and 2002; Smitherman 
and Sontheimer, 2001; Verrecchia and Herve, 1997).  The mechanism of how tamoxifen 
blocks ICl,swell is unclear and may not involve block of nuclear estrogen receptors.  
Nevertheless, tamoxifen is a prodrug and its cellular metabolism increases its affinity for 
and block of the estrogen receptor.     
DCPIB, a non-diuretic acylaryloxyacid analogue of ethacrynic acid, has become 
the standard selective inhibitor of ICl,swell.  In drug discovery studies, this agent initially 
was shown to block swelling of astrocytes in vitro and in the cat cerebral cortex in vivo 
(Bourke et al., 1981; Cragoe et al., 1982) identifying a potential clinical application, but 
the underlying mechanism of action was not identified.  The novel role of DCPIB in 
selective inhibition of ICl,swell was not recognized until Decher et al. (2001) demonstrated 
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that DCPIB (10 µM) fully inhibited ICl,swell  in a voltage-independent manner in guinea-pig 
atria and prevented the shortening of action potential duration (APD).  They also showed 
that DCPIB blocks ICl,swell in calf bovine pulmonary artery endothelial (CPAE) cells with 
an IC50 of 4.1 µM, and DCPIB almost fully blocks the swelling-activated Cl
- current in 
Xenopus oocytes while showing no significant effect on ICl,Ca in CPAE cells, CLC family 
of Cl- channels, heterologously expressed human cystic fibrosis transmembrane 
conductance regulator (hCFTR) in Xenopus oocytes, and several of the anion and cation 
conductance found in guinea-pig heart including ICl,PKA, IK, IKs, IK1, INa, and ICa (Decher 
et al., 2001).  A recent study of glutamate transport pathways in glial cells shows that 
DCPIB blocks Cx43, glutamate transporter (GLT-1), and cysteine-glutamate 
heteroexchanger (xCT); however, DCPIB fails to suppress GLAST (glutamate aspartate 
transporter) often found in astrocytes and vesicular glutamate release in synaptosomes 
from rat forebrain (Bowens et al., 2013).  More recently, the latest work by Deng et al. 
(2016) strongly suggests that DCPIB can also bind to inwardly rectifying K+ (Kir) channels 
with relatively weak affinity for PIP2 whereas DCPIB fails to block Kir isoforms such as IK1 
which is known to demonstrate higher affinity for PIP2.     
 
 
1.4  Molecular Identity of ICl,swell 
  Although DCPIB is identified as the most selective in blocking ICl,swell, none of the 
aforementioned blockers including DCPIB are considered high affinity and suitable to 
employ as tool for protein isolation.  Once bound, they all unbind and show full reversibility 
upon washout.  Therefore, without available high affinity irreversible blockers of ICl,swell 
and perhaps overly influenced by the name “swelling-activated chloride channel,” 
investigators used osmotic swelling as a tool to peruse the molecular identity of the 
channel.  In more than a decade of experiments, this lead to claims that ICl,swell  was due 
to P-glycoprotein (MDR-1), pICln, phospholemman, CLC3, TMEM16A (anoctamin 1), and  
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bestrophin 1 (BEST1), but in each case, the proposed molecular identity for ICl,swell was 
refuted (Hume et al., 2000; Jentsch et al., 2002; Nilius et al., 1997; Kunzelmann, 2015 ).  
For example, both anoctamin 1 and BEST1 require Ca2+ for activation and fall into the 
category of calcium-activated chloride channels (CaCC), but ICl,swell appears to be Ca
2+-
independent  and critical biophysical properties are distinct from those of anoctamin 1 
and BEST1.  Among the molecular candidates listed, perhaps CLC3 provided the 
strongest case for being labeled as ICl,swell.  This Cl
- channel was identified as cardiac 
ICl,swell based on functional expression of a guinea pig cardiac clone in NIH/3T3 fibroblasts 
(Duan et al., 1997, 1999).  According to Duan et al. (1997), expression of guinea pig CLC3 
lead to swelling-activated Cl- currents sharing the same biophysical properties of ICl,swell 
and its modulation by PKC and serine/threonine phosphatases.  However, Jentsch et al. 
(2002) discredited the role of CLC3 in eliciting ICl,swell, as CLC3 is normally clustered to 
intracellular membranes and its up-regulation does not necessarily give rise to ICl,swell.  Li 
et al. (2000) also argues that increased expression of CLC3 prompts currents with 
inconsistent permeability sequence where Cl- > I- accompanied by incorrect 
pharmacological response than ICl,swell.  Even though CLC3 antisense appeared to 
minimize ICl,swell in ciliary epithelium (Wang et al., 2000), Xenopus oocytes and HeLa cells 
(Satterwhite et al., 2002), it was difficult to exclude the possibility that CLC3 was a 
regulator of ICl,swell rather than the channel itself, and CLC-family proteins were shown to 
serve as proton-Cl- exchangers (Scheel et al., 2005).  Finally, knockout of CLC3 failed to 
affect neuronal ICl,swell (Stobrawa et al., 2001), and Hume, Duan and coworkers 
(Yamamoto-Mizuma et al., 2004) found ICl,swell also persisted in cardiac and smooth 
muscle myocytes, although aspects of its regulation were altered.  
Of the approaches taken to identify ICl,swell, swelling has been the most 
instrumental in activating the current as the channel name suggests as the ult imate 
means to verify the presence of ICl,swell.  The latest molecular entity identified to adopt 
swelling as the primary approach is SWELL1 by Qiu et al. (2014) or LRRC8A by Voss et 
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al. (2014).  Even though their approach taken is novel, swelling is still a prerequisite prior 
to halide (I-) quenching (Qiu et al., 2014; Voss et al., 2014).  Although swelling plays an 
important role in current activation, it is just one factor among a number of existing critical 
regulators identified to date that shape ICl,swell signaling cascade as comprehensibly 
defined by Baumgarten and co-workers (Deng et al., 2010a; Browe et al., 2004 and 2006; 
Ren et al., 2008; Ren and Baumgarten, 2005; Du et al., 2004).  Key components of the 
signaling cascade are summarized by Deng et al. (2010a).  Fig.1 shows that in rabbit 
ventricular myocytes, osmotic swelling is upstream of angiotensin II (AngII), endothelin-1 
(ET-1), and epidermal growth factor (EGF) which represent three specific peptide 
molecules known to elicit ICl,swell each by activating AT1 receptors (AT1R), ETA receptors 
(ETAR), and EGF receptors (EGFR), respectively (Deng et al., 2010a; Browe et al., 2004 
and 2006; Ren et al., 2008).  ET-1 elicited ICl,swell is downstream of AngII and upstream of 
EGF and phosphoinositide-3-kinase (PI-3K) signaling cascades; therefore, suppressing 
EGFR or PI-3K blocks ICl,swell after its activation by ET-1 whereas antagonizing AT1R 
remains ineffective (Fig. 1).  Direct blockade of NOX (Active NOX2) shown in Fig. 1 
inhibits ICl,swell in the presence of osmotic swelling, AngII, ET-1, and EGF, which places 
NOX downstream of all four upstream signaling cascades.  Reactive oxygen species 
(ROS) production by NOX help elicit ICl,swell but blocking mitochondrial Complex I 
completely inhibits ICl,swell.  Directly augmenting ROS release at Complex III also leads 
to ICl,swell and shows insensitivity to NOX inhibitors.  This places mitochondria 
downstream of NOX in the signaling cascade (Fig. 1).  Lastly, exogenous H2O2 has been 
known to fully elicit ICl,swell despite blockade of all the aforementioned upstream activators; 
therefore, H2O2 acts to turn on DCPIB sensitive ICl,swell at or near the channel itself (Fig. 
1).  This makes H2O2 the most proximate to ICl,swell and furthest from osmotic swelling in 
the signaling cascade known to date.  The ICl,swell regulatory signaling cascade is, 
therefore, very complex involving a number of critical regulators from osmotic swelling 
down to H2O2.  Thus, swelling alone cannot ultimately serve as a basis for conclusively  
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FIG. 1:  ICl,swell signaling cascade in heart.  Exogenous stimuli such as osmotic 
swelling, AngII, ET-1, EGF, and H2O2 lead to ICl,swell.  Osmotic swelling and AngII 
activated ICl,swell through AT1Receptors, ET-1 through ETAReceptors, and EGF through 
EGF Receptors; in addition, these 3 receptors were up stream of PI-3K and NOX2.  
Superoxide or H2O2 generated most likely by NOX2 stimulated mitochondrial ROS 
production via Cplx III.  Antimycin A and diazoxide augmented Cplx III ROS generation 
independent of NOX2.  Ebselen effectively scavenged H2O2 from NOX2 and/or 
mitochondria.  Green represents stimulation and red shows suppression [21].  
Activation (), inhibition (), and excluded pathways (X) are indicated.  
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identifying the channel.   
 
 
1.5  Identification of Ebselen (Ebs):  High Affinity Blocker of ICl,swell 
 Ebselen (2-phenyl-1,2-benzisoselenazol-3(2H)-one; also called PZ51, DR3305, 
and SPI-1005) is a selenoorganic small molecule which has been known for more than 
two decades as a glutathione peroxidase (GPx)-mimetic (Sies, 1993; Nakamura et al., 
2002; Sakurai et al., 2006).  Some common targets of Ebs range from hydrogen peroxide 
and small organic hydroperoxides to cholesterol hydroperoxides (Sies, 1993), and Ebs 
also is active against free radicals and singlet oxygen (Sies, 1993).  Based on its GPx-
mimetic activity, Ebs is utilized as a ROS scavenger, and Ebs at 15 M is sufficient to 
provide complete block of ICl,swell and the role of mitochondrial ROS was confirmed by 
flow cytometry (Deng et al., 2010a, 2010b).  However, Ebs was recently reported to 
suppress NOX2 activity in broken cell preparations (Smith et al., 2012). 
Based on the ability of Ebs to act as a GPx-mimetic and its ability to suppress 
ICl,swell (Deng et al., 2010a, 2010b), we utilized Ebs in preliminary experiments on ICl,swell 
following ROS augmentation at Complex III in the DI TNC1 astrocyte cell line.  To our 
surprise, 15 M Ebs suppressed ICl,swell with fast kinetics, suggesting it possessed much 
greater than expected affinity, and we found that block was irreversible within the time 
scale of patch clamp studies.  Together, these findings lead us to postulate that Ebs might 
be useful as a high affinity irreversible ICl,swell blocker and as a tool to directly isolate the 
target responsible for current block.  Experiments designed to characterize the action of 
Ebs and its congeners identified several compounds that fully and irreversibly suppressed 
ICl,swell at concentrations as low as 5 nM.  Moreover, evidence suggests that covalent 
binding of Ebs and its congeners to critical sulfhydryl groups modulate the conductance 
of the channel.  Finally, the site of block ICl,swell by Ebs and its congeners must be distal 
in the signaling cascade that activates the channel because block could not be overcome 
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by exposure to exogenous H2O2, the most distal regulator of ICl,swell previously identified.  
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METHODS 
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2.1  DI TNC1 Astrocyte Cell Culture 
DI TNC1 cell line was originally established by Radany et al. (1992) by transfecting 
primary astrocytes from diencephalon of a 1 day-old Sprague Dawley rat with a DNA 
construct that contains the oncogenic early sequence of SV40.  It is positive for glial 
fibrillary acidic protein (GFAP) and aquaporin 4 (AQP4; astrocyte water channel) 
negative.  DI TNC1 cells are phenotypically equivalent to type 1 astrocytes and lack 
specific epitopes characteristic of type 2 astrocytes, and over 90% of transfected cells 
show the presence of SV40 T antigen upon immunostaining (Radany et al., 1992).  DI 
TNC1 cells (American Type Culture Collection; ATCC CRL-2005, passages 3-17) were 
grown on Corning CELLBIND (60 x 15 mm) pretreated culture dishes using DMEM 
(Corning Cellgro, 10-013-CV) supplemented with 10% v/v fetal bovine serum (FBS) 
(Sigma-Aldrich, F2442), and 1% v/v penicillin/streptomycin (Cellgro 30-002-CI).  The cells 
were grown at 37 °C under 5% CO2 and 95% O2.  After cells reached 80-90% confluency, 
a brief wash with 5-7 mL of Dubecco’s phosphate buffered saline without calcium and 
magnesium (Thermo Scientific, HyClone SH30028.02) followed by incubation with 3-5 
mL of 0.25% trypsin-EDTA (Gibco/Thermo Fisher Scientific, 25200056) for 10-20 min at 
37 °C was performed to dislodge the cells while gently tapping the culture dish.  Additional 
DMEM (5-8 mL) was then used to wash the cells into 15 mL conical centrifuge tubes prior 
to centrifugation at 2500 rpm for 3-5 min on a table top centrifuge.  Supernatant was 
removed to isolate the pellet prior to resuspension in 8-12 mL of DMEM.  About 1-2 mL 
were plated for the next passage, and the rest were incubated at 37 °C for 1 h in 5% CO2 
prior to use.  After recovery, DI TNC1 astrocytes were resuspended in appropriate 
experimental bath solution.  We also used HEK293 cells, gift of Dr. Gea-Ny Tseng, in 
some experiments and the cells were subjected to similar culturing conditions.        
 
 
2.2  Experimental Solutions and Drugs 
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Solutions were designed to isolate the Cl- current.  The isosmotic bath solution 
(1T; 320 mOsm/kg; T denotes times isosmotic) contained (in mmol/L):  90 N-methyl-D-
glucamine-Cl, 3 MgCl2, 10 HEPES, 10 glucose, 5 CsCl, 0.5 CdCl2, and mannitol was 
used to adjust bath solution osmolarity (pH 7.4; adjusted with CsOH).  Hyposmotic (0.8T) 
bath solution contained less mannitol.  Standard pipette solution contained:  110 NMDG-
glucuronate, 20 TEA-Cl, 0.15 CaCl2, 10 Cs2EGTAH2, 10 HEPES, 5 Mg-ATP, and 0.1 
Tris-GTP (pH 7.2; CsOH).  Symmetrical Cl- pipette solution contained:  82 CsCl, 28 Cs-
Aspartate, 20 TEA-Cl, 0.15 CaCl2, 8 Cs2EGTAH2, 10 HEPES, 5 Mg-ATP, and 0.1 Tris-
GTP (pH 7.2; CsOH).   
Stock solutions of ebselen (Ebs; 17 mM, Cayman), ebselen-p-yne (Ebs-p-yne; 15 
mM, M. Hartman and P. Dupart, Dept. of Chemistry, VCU), ebselen-biotin (Ebs-biotin; 15 
mM, M. Hartman and P. Dupart, Dept. of Chemistry, VCU), ebselen oxide (EbO; 15 mM, 
Sigma), Thr101 (19 mM, Calbiochem), DCPIB (10 mM, Tocris), diazoxide (Diaz; 40 mM, 
Sigma), antimycin A (AntiA; 10 mM, Sigma), and VAS2870 (5.5 mM, Enzo) purged under 
argon were prepared in DMSO and stored in -20 °C in aliquots until use.  Stock solutions 
of MTSES (110 mM, Toronto), MTSET (110 mM, Toronto), and MTSEA biotin (50 mM, 
Toronto) were dissolved in water and prepared fresh on the day of the experiment.  
Hydrogen peroxide (H2O2; 500 mM, Fisher Scientific, 7722-84-1) was also prepared fresh 
on the day of use.  Chemical structures for Ebs, Ebs-p-yne, EbO, and Thr101 can also 
be found in Fig. 1 of the Appendix.  Structure of Ebs-biotin is shown in Fig. 5 of the 
Appendix.  Structures of diazoxide, antimycin A, DCPIB, Ebs and its congeners, and 
VAS2870 are as follows: 
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2.3  Whole Cell Patch-Clamp and Electrophysiological Recordings 
 After 1 h recovery at 37 °C under 5% CO2, DI TNC1 cell resuspensions in 1T or 
0.8T were gently pipetted onto the glass-bottomed patch chamber on the stage of an 
 
 
 
      
 
               VAS2870 
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inverted light microscope (Nikon) equipped with 40x LWD Hoffman modulation optics and 
coupled to a high resolution video camera (CCD72, Dage-MTI) for visualizing the cells.  
After settling, the cells were suprafused with 1T or 0.8T bath solution at 2-3 mL/min while 
recording at room temperature of 18-21 °C.  The patch pipettes were pulled from 7740 
thin-walled borosilicate capillary tubing (Sutter) and fire-polished to a tip diameter of 
approximately 1-3 M with a bath solution resistance of 3-5 MΩ.  Membrane currents 
were recorded under whole cell mode using an Axopatch 200B amplifier and Digidata 
1322A data acquisition system (Axon).  A 3 M KCl agar bridge was used as the ground 
electrode.   Seal resistances of 10-50 GΩ were typically obtained prior to applying 
negative pressure.  Access resistances were 4-10 MΩ before compensation (typically 40-
60%).  All measured membrane potentials were corrected for the liquid junction potential 
(LJP).  DI TNC1 cells were then dialyzed 2-5 min prior to recording membrane currents.   
Voltage-clamp protocol and data acquisition were established by pClamp 8.2 
(Axon).  Successive 500 ms pulses were made from a holding potential of -60 mV to test 
potentials from -100 to +60 mV in +10 mV increments.  Membrane currents were low-
pass filtered at 2 kHz and digitized at 5 kHz, and selected current traces were low-pass 
filtered at 500 Hz for presentation.  I-V relationships were generated from corresponding 
membrane current traces.  Data were recorded without correcting for leak currents and 
expressed as pA/pF (current density) to normalize variations in cell size to capacitive 
membrane area.  Current amplitudes for both activation and block were measured relative 
to zero current rather than the initial current recorded upon breaking into a cell.  This 
approach slightly overestimated the swelling-activated chloride current and 
underestimated the fraction of current that was blocked because leak current could not 
be independently measured and, therefore, was not subtracted.  For clarity, in some 
instances data are plotted and expressed as fractional block by normalizing to current 
density after activation of ICl,swell.   
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2.4  Intracellular Application of Drugs by Back-Filling 
 Patch experiments performed under isosmotic conditions (1T) utilized intracellular 
diazoxide (Diaz [in]; 53 M) or antimycin A (AntiA [in]; 10 M) included in the pipette 
solution to activate ICl,swell.  Selected experiments were done using a hypoosmotic 
challenge with 0.8T to activate ICl,swell.  In some of these studies, either ebselen (Ebs [in]; 
30 M) or DCPIB (DCPIB [in]; 30 M) were included in the pipette solution.  To be able 
to collect data before dialysis of the cell by pipette solution was complete, patch-pipettes 
were dipped in appropriate drug-free pipette solution for 30-90 s utilizing capillary action 
to pull in a ~1-2 mm column of drug-free pipette solution prior to back-filling the pipette 
with proper drug-containing media.  Diffusion of drug within the tip of the pipette allowed 
sufficient time to mount the pipette, form a gigaseal, break-in, and begin recording 
membrane currents while currents were still near their control values. 
 
 
2.5  Reversibility of DCPIB 
 Demonstration of the reversible nature of block by DCPIB, the most selective 
blocker of ICl,swell known to date, can be found in Fig. 8 of the Appendix.   
 
 
2.6  Total Number of Channels Per DI TNC1 Astrocyte 
 Based on reported open probability, Po, of 0.68 and unitary conductance, γ, of 28 
± 1 pS of ICl,swell at strongly positive potentials by Duan et al. (1997) and incorporating our 
experimentally observed macroscopic currents,  ~1000 - 3000 pA at +60 mV with an ECl 
of -41 mV, we can estimate the total number of ICl,swell channels, N, in an astrocyte.  The 
unitary current, i, is given by: 
    i = γ (Etest - ECl)  
where Etest is the test potential, +60 mV, and the macroscopic ICl,swell, I, is given by:  
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I = i N Po  
Substituting for i yields and then solving for N: 
I = γ (Etest - ECl) N Po 
N = I [γ (Etest - ECl) Po]-1  
gives ~520-1560 channels per DI TNC1 astrocyte.  Even at low nanomolar 
concentrations, blockers applied in flowing bath solutions are in excess of the number of 
potential binding sites and can be considered to remain constant during the experiment. 
 
 
2.7  Model of ICl,swell Block by Ebs and Its Cogeners 
One caveat in describing block by Ebs and Ebs-p-yne is whether block is 
irreversible or very slowly reversible.  We ascertained the rate constants for block of 
current assuming 1:1 bimolecular pseudo-first order kinetics and that binding to the 
receptor was proportional to current block.  Experimentally we found that block by Ebs 
and its congeners could be well-described by a single exponential and was irreversible 
over the time course studied.   
The scenario can be described by drug (D) bound to its receptor (R): 
    k1          k2 
  →     
   R + D  ←  RD         R-D 
    k-1  
where k1 and k-1 are forward and reverse rate constants for formation of a reversible 
intermediate, RD, and k2 is the rate constant for irreversible conversion of RD to R-D, 
(e.g., formation of a covalent bond).  We cannot, however, independently identify the RD 
state or distinguish whether just R-D or both RD and R-D block ICl,swell.  To simplify the 
analysis, we described the kinetics of current block (rather than drug-receptor binding) 
based on fits to a single exponential function, giving a time constant, , and its inverse, a 
rate constant, K (see p. 56).     
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Given the possibility that Ebs and its congeners may eventually reverse provided 
enough time, for purposes of comparison, we estimated an apparent IC50 for current block 
based on the concentration giving full block. This approach previously was used by 
others.  For example, two studies of the action of Ebs to bacterial proteins report an IC50 
of ~100 nM for Ebs binding to Ag85c (Favrot et al., 2013) and IC50 of ~6.9-17.2 nM for 
Ebs binding to TcdB (Bender et al., 2015) even though these authors argued Ebs binding 
lead to irreversible covalent modification of the target proteins.         
 
 
2.8  Statistics   
In order to decrease variability, each cell was used as its own control.  Data are 
reported as mean ± SEM; n denotes the number of cells for current density or rate 
constant (K) of block determination.  One-way repeated-measures ANOVA were 
performed and all pairwise comparisons made by the Holm–Sidak method.  For 
calculating K under conditions of apparent irreversible block, time courses were fit to a 
pseudo-first order exponential decay (SigmaPlot) assuming 1:1 bimolecular interaction of 
drug and its receptor after accounting for the time required for equilibration of drug in the 
tissue bath. 
The kinetics of block by Ebs (Control) were compared to those of EbO and Thr101 
using block of 20-80% of the current because the rapid block by Ebs was difficult to fit to 
an exponential function.  Because normality test on the raw data failed, instead we 
analyzed the natural log of the data, which passed normality testing.  We compared EbO 
and Thr101 to Ebs (Control) by a one-way ANOVA and the Holm-Sidak method.   
 
        
  
21 
 
 
 
 
CHAPTER 3 
RESULTS 
  
22 
 
3.1  Identification of ICl,swell in DI TNC1 Astrocytes    
 Fig. 2 demonstrates typical outwardly-rectifying Cl- currents characteristic of 
ICl,swell in DI TNC1 astrocytes during 0.8T hypo-osmotic challenges with physiological (A-
C) and symmetrical Cl- gradients (D-F).  Panel A and D represent current traces 
generated when -100 to +60 mV voltage steps were applied for 500 ms in 10 mV 
increments.  Panel B and E are the corresponding I-V relationships and cell capacitances.  
Panel C and F present summary data illustrating fractional block of the steady-state 
swelling-induced current in 0.8T at +60 mV by 10 μM DCPIB, a selective inhibitor of ICl,swell 
(Decher et al., 2001).       
As expected for ICl,swell (Baumgarten and Clemo, 2003), the currents elicited in 
0.8T outwardly rectified in both physiological and symmetrical Cl- solutions and were 
blocked by DCPIB.  The current activated by 0.8T at +60 mV was 33.3 ± 6.9 pA/pF (n = 
4) in physiological Cl- and 34.8 ± 10.0 pA/pF (n = 5) in symmetrical Cl-.  With a 
physiological Cl- gradient, the observed Erev was between -35 and -38 mV, which is close 
to the calculated value of the Nernst equilibrium potential for Cl- (ECl), -41 mV, after 
correcting for the liquid junction potential.  With a symmetrical Cl- gradient, Erev was 
almost exactly 0 mV as predicted for ECl.  Addition of DCPIB (10 µM, 5-15 min) blocked 
87.5 ± 3.2% (n = 4) (C) and 92.5 ± 1.3% (n = 5) (F) of the swelling-activated Cl- current 
at +60 mV (for both, P < 0.001).  Although outward rectification was observed with both 
physiological and symmetrical Cl- gradients, the rectification was greater under 
physiological than symmetrical conditions, as previously reported for ICl,swell (Vandenberg 
et al., 1994; Duan et al., 1997).  Thus, current elicited by osmotic swelling of DI TNC1 
astrocytes shared the biophysical and pharmacological characteristics of ICl,swell.   
Two technical issues should be noted.  First, the current density of ICl,swell can vary 
with the passage number.  For example, ICl,swell in another group of astrocytes was 240.3 
± 63.5 pA/pF (n = 4) at +60 mV in 0.8T, a much greater current density than that shown 
in Fig. 2.  Nevertheless, DCPIB very strongly blocked 99.0 ± 0.3% of ICl,swell in these cells  
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FIG. 2:  Activation of outwardly rectifying ICl,swell and block by DCPIB (10 µM, 5-
10 min) following hypo-osmotic challenge with physiological (A-C) and 
symmetrical (D-F) Cl- gradients in DI TNC1 astrocytes.  A and D. Current traces 
upon stepping for 500 ms to -100 mV to +60 mV in 10 mV increments from a holding 
potential of -60 mV under conditions that isolate the Cl- current.  B and E. Current-
voltage (I-V) relationships at break in (blue), after steady state current activation with 
0.8T hypo-osmotic bath solution (green), and after block with DCPIB (red) in 0.8T; plots 
of I-V relationships were corrected for measured liquid junction potential.  C and F. 
Block of 0.8T-induced current by DCPIB at +60 mV.  DCPIB blocked 87.5 ± 3.2% (n = 
4, P < 0.001) and 92.5 ± 1.3% (n = 5, P < 0.001) of swelling-induced current in 
physiological (C) and symmetrical (F) Cl- solutions, respectively.  Physiological Cl- 
solutions contained 20 mM Cl- inside the patch pipette and 102 mM Cl- in bath solution, 
and symmetrical Cl- solutions contained 102 mM Cl- in both (see insets, B and E).  
Current densities were calculated based on measured membrane capacitance.  
Repeated measures ANOVA were based on current densities and are presented as 
fractional current densities and fractional block for clarity.  
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as well (n = 4, P < 0.001).  Second, as mentioned in Methods, current amplitudes for 
both activation and block were measured relative to zero current rather than the initial 
current recorded upon breaking into a cell.  The approach adopted slightly overestimated 
the swelling-activated current and underestimated the fraction of current that was blocked 
because leak current could not be independently measured and was not subtracted.  
Failing to subtract leak likely explains why DCPIB appeared to block a greater fraction of 
ICl,swell when the swelling-induced current density was greatest (i.e, 240 pA/pF vs 33 
pA/pF).  If instead we measured currents relative to the current at break in, we would 
have underestimated activation of ICl,swell in the presence of partial current activation (pre-
activation) under isosmotic conditions, as is sometimes the case, and overestimated the 
fraction of current blocked by DCPIB.  Consistent with this idea, preliminary analyses 
measuring currents relative to that at break in sometimes resulted in >100% block by 
DCPIB.     
Because astrocytes express various glutamate receptors and glutamate 
transporters (Seifert et al., 2006), we assessed whether these transport processes 
contributed to the measured Cl- current.  Application of external glutamate (1-3 mM) failed 
to affect the current attributed to ICl,swell (n = 4, P = 0.490; ns; Appendix, Fig. 11).  Similarly, 
CFTR(inh)-172 (20 M), a highly selective inhibitor of CFTR, also failed to affect ICl,swell 
(n = 6, P = 0.079; ns; Appendix, Fig. 12). 
 
 
3.2  Effect of Ebselen (Ebs) on ICl,swell 
3.2.1  Block of ICl,swell by Ebs 
 Intracellular diazoxide (53 M; Diaz [in]) elicited an outwardly-rectifying Cl- current 
characteristic of ICl,swell in physiological Cl
- gradient.  Diaz, a KATP channel opener 
displaying sensitivity toward mitoKATP (Garlid and Halestrap, 2012), augments Complex 
III ROS production independent of NOX and leads to ICl,swell activation (Deng et al., 
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2010a; Queliconi et al., 2011).  Fig. 3 demonstrates block of ICl,swell following activation 
when diazoxide was back-filled in the patch pipette as described in Methods.  Unless 
otherwise specified, experiments were performed under conditions isosmotic (1T) with 
equal pipette and bath osmolarity.  Typical current traces, corresponding I-V relationships, 
summary data demonstrating fractional block at +60 mV by Ebs (15 M) added to flowing 
bath solution, and a typical time-course for the full experiment are shown.  Ebs blocked 
93.9 ± 5.6% (n = 15, P < 0.001) of the Diaz [in]-induced current (Fig. 3).  The block of 
ICl,swell was relatively fast with complete block in 2-3 min after addition of Ebs.     
 
3.2.2  Diazoxide-induced ICl,swell failed to rundown 
To rule out ICl,swell rundown in the presence of Diaz [in] as the cause of current inhibition 
upon addition of Ebs, a control experiment tested whether activation of ICl,swell by Diaz [in] 
was ephemeral or maintained for the duration of exposure (Fig. 4).  After reaching steady-
state activation at ~20 min, ICl,swell remained persistently elevated for ~50 min.  Rather 
than rundown, the summary data showed a small but statistically insignificant increase in 
current that may have resulted from uncertainty in the precise timing of reaching steady-
state activation.    
 
 
3.3  High Affinity Block of ICl,swell by Ebs 
3.3.1  Ebs blocked ICl,swell with nanomolar affinity 
 The block of ICl,swell in cardiac myocytes with 15 M Ebs was previously 
demonstrated by Deng et al. (2010a) following activation with endothelin-1 (ET-1).  The 
rapid onset of block by Ebs in DI TNC1 cells (complete block in 2-3 min; Fig. 3) suggested 
Ebs might act with high affinity for its target.  After preliminary studies showed Ebs fully 
blocked Diaz [in]-induced ICl,swell at 1.5 M and 150 nM (both, n = 1), the response to 
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FIG. 3:  Block of ICl,swell by Ebselen (Ebs).  ICl,swell was activated under isosmotic 
(1T) conditions by back-filling patch pipette with 53 µM diazoxide (Diaz [in]; see inset) 
and was rapidly blocked by adding 15 µM Ebs in bath.  Current traces (A) and I-V 
relationships (B) showing break in (blue), activation with Diaz [in] (green), and block 
with Ebs (red); time lag before onset of block represents transit time in perfusion 
system. C. Block of Diaz-induced current by Ebs at +60 mV.  Ebs blocked 93.9 ± 5.6% 
(n = 15, P < 0.001) of the Diaz-induced current (148.5 ± 20.4 pA/pF) in a physiological 
Cl- gradient.  D. Time-course for Diaz-induced current activation, block by Ebs, and 
time of break in (blue square); symbols correspond to B.  Patch pipette was back-filled 
with Ebs at 0 min.  Dash line indicates current upon break in. 
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FIG. 4:  ICl,swell failed to rundown during prolonged activation (~1 hr).  A. Current 
traces at break in (blue), after full activation of ICl,swell by Diaz [in] (green), and after 
prolonged activation (steady-state; red) recorded at times indicated by (1), (2) and (3) 
in C.  B. Diaz-induced current after full activation (100.6 ± 33.3 pA/pF) at (2) and in 
steady-state (3) were not distinguishable (n = 6, P = 0.084; ns).  C. Time-course 
showing when corresponding current traces were taken. 
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45 nM Ebs was characterized in detail.  Fig. 5 shows that 45 nM Ebs fully blocked ICl,swell 
and that increasing superfusate Ebs to 15 μM did not significantly block additional current.  
Nevertheless, block by 45 nM Ebs demonstrated slower kinetics as expected.  Assuming 
a simple 1:1 bimolecular reaction between Ebs and its receptor, full block at 45 nM 
suggests that that the IC50 for block of ICl,swell by Ebs must be <5 nM. 
 
3.3.2  Ebs failed to washout 
 The apparent Ebs IC50 of <5 nM and the time course of development of block 
suggest that the rate of dissociation of Ebs must be very slow or irreversible.  Fig. 6 
demonstrates that block of ICl,swell by 15 μM Ebs failed to washout in 1T bath solution.  
Ebs blocked 94.1 ± 0.9% of the current, and 94.1 ± 1.5% remained blocked after 5-25 
min of washout (n = 6, P = 0.987; ns).  To rule out the possibility that the apparent 
irreversibility of Ebs block was due to an interaction between diazoxide in the pipette 
solution (Diaz [in]) and Ebs added to the bathing solution, an alternative approach was 
used to activate ICl,swell.  Antimycin A inhibits the mitochondrial electron transport chain 
at Complex III, causes ROS to spill into the cytosol, and like diazoxide, activates ICl,swell 
(Deng et al., 2010a).  Fig. 7 illustrates the activation of ICl,swell when the patch pipette was  
backfilled with antimycin A (10 M; AntiA [in]), block by Ebs, and attempted washout of 
Ebs in 1T.  Both Anti [in] (Fig. 7) and Diaz [in] (Fig. 6) elicited similar outwardly rectifying 
currents with the expected ECl.  Furthermore, AntiA [in]-activated ICl,swell was blocked by 
Ebs, 84.3 ± 2.9% (n = 4, P < 0.001), and block by Ebs failed to significantly washout in 
1T after 20-60 min (n = 4, P = 0.085; ns).  Therefore, block of ICl,swell by Ebs appeared to 
be irreversible within the timescale of the patch clamp recording and did not depend on 
the agent used to elicit ICl,swell in 1T. 
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FIG. 5:  Ebselen blocked ICl,swell with high affinity.  Diaz [in]-induced ICl,swell was 
blocked by 45 nM Ebs.  Current traces (A) and I-V relationships (B) at break in (blue), 
after activation with Diaz [in] (green), and after block with 45 nM Ebs (red; open circle) 
and 15 µM Ebs (dark red; downward open triangle).  C. Fractional block of Diaz-
induced current by Ebs.  Ebs (45 nM) blocked 92.5 ± 2.2% (n = 3, P < 0.001) of the 
Diaz [in]-induced current (101.9 ± 20.9 pA/pF), and increasing Ebs to 15 M failed to 
provide addition block (n = 3, P = 0.385; ns).  D. Time-course for current activation by 
Diaz [in], block by 45 nM and 15 μM Ebs, and time of break in.  
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FIG. 6:  Ebselen block of diazoxide-induced ICl,swell failed to washout.  ICl,swell was 
activated with Diaz [in] and blocked by adding 15 M Ebs to bath solution.  ICl,swell did 
not recover on washout (WO) in Ebs-free 1T bathing media.  Current traces (A) and I-
V relationships (B) showing activation of ICl,swell with Diaz (green), block with 15 M 
Ebs (red), and washout with 1T (dark red).  C. Ebs (15 M) blocked 94.1 ± 0.9% (n = 
6, P < 0.001) of the Diaz [in]-induced current (105.0 ± 15.1 pA/pF) and failed to washout 
in 1T (n = 6, P = 0.987; ns).  D. Time-course for activation, block and attempted 
washout; time of break in indicated by filled square (blue).     
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FIG. 7:  Ebselen blocked antimycin A-induced ICl,swell and failed to washout.  
ICl,swell was activated by 10 µM antimycin A in pipette solution (AntiA [in]; see inset) 
and was rapidly blocked with 15 µM Ebs.  Current traces (A) I-V relationships (B) 
showing break in (blue), after activation with AntiA [in] (green), block with Ebs (red), 
and attempted Ebs washout (WO) in 1T (dark red).  C. Fractional block of AntiA-
induced current and washout.  Ebs (15 M) blocked 84.3 ± 2.9% (n = 4, P < 0.001) of 
AntiA [in]-induced current (54.9 ± 15.4 pA/pF) and block failed to significantly washout 
in 1T (n = 4, P = 0.085; ns).  D. Time-course for the current activation by AntiA [in], 
block by Ebs, attempted washout, and time of break in. 
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3.4  H2O2 Failed to Reactive ICl,swell Following Ebs Block 
The fact that Ebs blocked ICl,swell elicited by activators of mitochondrial ROS 
production suggests that its site of action is distal in the signaling cascade that leads to 
activation of ICl,swell by osmotic swelling and signaling molecules (Deng et al., 2010a).  
Because H2O2 is the most downstream activator of ICl,swell identified to date (Deng et al., 
2010a), we tested whether the site of block by Ebs is upstream or downstream of the 
current activated by H2O2.  Fig. 8 demonstrates that Ebs blocked 92.5 ± 2.2% of AntiA [in]-
induced ICl,swell, and 85.5 ± 6.3% remained blocked following Ebs washout (2-5 min) and 
subsequent H2O2 superfusion (15-20 min).  Failure H2O2 to reactivate ICl,swell after block 
by and washout of Ebs (n = 3, P = 0.322, ns) implies Ebs acts downstream to H2O2 in the 
signaling cascade.  In contrast, if Ebs simply acts as a GPx mimetic and quenches ROS 
(Nakamura et al., 2002; Sakurai et al., 2006; Deng et al., 2010a, 2010b), one would 
expect reactivation of ICl,swell by H2O2 applied after washout of Ebs.  
This observation leads to several possibilities.  Since H2O2 is a major form of ROS 
that crosses the plasma membrane barrier, Ebs could directly target an intracellular 
source of ROS or a proximate regulator responsible for ICl,swell.  On the other hand, 
although H2O2-induced activation of ICl,swell is documented in cardiac myocytes (Browe 
and Baumgarten, 2004; Ren et al., 2008; Deng et al., 2010a), HeLa cells (Shimizu et al., 
2004) and HTC cells (Varela et al., 2004), to our knowledge the role of ROS and activation 
of ICl,swell by H2O2 has not been documented in DI TNC1 astrocytes.  Thus, one might 
argue that failure of H2O2 to overcome Ebs block reflects differences in signaling 
responsible for activating ICl,swell rather than the site of Ebs block in the signaling cascade.  
To exclude this possibility, we tested whether H2O2 elicited ICl,swell in DI TNC1 astrocytes 
in 1T bathing media.  As shown in Fig. 9, exposure to 500 μM H2O2 evoked an outwardly 
rectifying current that was fully blocked by DCPIB.  This confirms the conclusion that Ebs 
is downstream of H2O2 in the signaling cascade and is the most proximate modulator of 
ICl,swell identified to date. 
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FIG. 8:  H2O2 failed to activate ICl,swell following block with Ebs.  ICl,swell was 
activated with AntiA [in], blocked with 15 µM Ebs, and Ebs was briefly washed out prior 
to adding H2O2.  Current traces (A) and I-V relationships (B) showing activation with 
AntiA [in] (green), block with Ebs (red), washout of Ebs (WO, blue), and attempted 
ICl,swell activation with H2O2 (dark yellow).  C. Fractional block of AntiA-induced current 
(100.2 ± 45.4 pA/pF) by Ebs, washout of Ebs from bath, and response to adding H2O2.  
Ebs blocked 92.5 ± 2.2% (n = 3, P < 0.001) of the normalized current, and block was 
unaffected by washout in 1T bath solution (n = 3, P = 0.471; ns).  H2O2 (500 M) failed 
to significantly reactivate ICl,swell after block by Ebs (vs. Ebs,  P = 0.322, ns; vs. WO, P 
= 0.566, ns; n = 3 for both).  D. Time-course for the experiment; time of break in 
indicated by open square (blue). 
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FIG. 9:  Activation of outwardly rectifying ICl,swell and block by DCPIB following 
H2O2 addition in physiological Cl
- gradient in DI TNC1 astrocytes.  ICl,swell was 
activated by H2O2 (500 M, 10  15 min) and blocked with 10 µM DCPIB (10 µM, 5 - 
10 min) in physiological Cl- (see inset).  Current traces (A) and I-V relationships (B) 
showing break in (blue), activation with H2O2 (green), and block with DCPIB (red).  C. 
Fractional block of H2O2-induced current (28.9 ± 5.2 pA/pF) by DCPIB; DCPIB blocked 
90.2 ± 1.3% (n = 4, P < 0.001) of the normalized current.   
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3.5  Ebs Congeners Lacking GPx Activity Completely Blocked ICl,swell 
3.5.1  EbO 
As Ebs demonstrates chemical structural congeners (Schewe, 1995, Zhao et al., 
2002; Sakurai et al., 2006), ebselen oxide (EbO), a congener readily produced by 
oxidation of Ebs in the presence of either H2O2 (Glass et al., 1988) or peroxynitrite (Daiber 
et al., 2000), was tested.  Unlike Ebs, EbO is not a GPx-mimetic and lacks the 
antioxidative profile of Ebs (Lass et al., 1996).  Since superoxide radical (O2
-●) or H2O2 
produced by NOX can directly stimulate ROS production via Complex III (Deng et al., 
2010a) and O2
-● is known to generate peroxynitrite in the presence of NO (Pacher et al., 
2007), block of ICl,swell with EbO was tested under the assumption that Ebs may be 
converted to EbO during ICl,swell activation.     
       
3.5.1(a)  Block of ICl,swell with EbO     
If Ebs blocks ICl,swell by scavenging ROS, EbO should be ineffective because EbO 
lacks ROS scavenging activity (Lass et al., 1996).  To the contrary, Fig. 10 shows that 
EbO (15 M) blocked 92.6 ± 1.7% (n = 5, P < 0.001) of the current elicited by Diaz [in].  
Moreover, block by EbO also appeared to be irreversible as 94.2 ± 1.8% of the current 
remained blocked after washout of EbO for 35-100 min (n = 5, P = 0.324; ns).  On the 
other hand, the kinetics of block by 15 M EbO was obviously slower than by 15 M Ebs 
(Ebs: 1.6 ± 0.3 min, n = 5; EbO: 11.9 ± 2.2 min, n = 7; P < 0.001).  Block with EbO required 
~20 min (Fig. 10), whereas block by the same concentration of Ebs was complete in 2-3 
min (Fig. 3).  The fact that a non-GPx-mimetic analog of Ebs induced complete block of 
ICl,swell with apparent irreversibility upon washout raises the possibility that Ebs and EbO 
act by a common mechanism that is independent of ROS scavenging.     
 
3.5.1(b)  EbO blocked downstream of H2O2 
 To determine whether EbO, like Ebs, acts at a site distal to H2O2, we attempted to  
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FIG. 10:  Ebselen oxide (EbO) blocked ICl,swell and failed to washout.  ICl,swell was 
activated with Diaz [in] and was blocked with 15 M EbO.  Current traces (A) and I-V 
relationships (B) showing ICl,swell activation with Diaz [in] (green), block with 15 M EbO 
(red), and attempted washout with EbO-free 1T bath solution (dark red).  C. Fractional 
block of Diaz-induced current (159.7 ± 62.4 pA/pF) by EbO and washout.  EbO (15 M) 
blocked 92.6 ± 1.7% (n = 5, P < 0.001) of the current and failed to washout in 1T (n = 
5, P = 0.324; ns).  D. Time-course of the experiment; time of break in indicated by blue 
square.   
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reactivate ICl,swell following block with EbO.  After activating ICl,swell with Diaz [in], EbO 
blocked 93.1 ± 1.4% (n = 4, P < 0.001) of the current and 95.0 ± 0.9% of block was  
maintained after failed attempts to reactivate ICl,swell with H2O2 (vs. EbO,  P = 0.186, ns;  
vs. WO, P = 0.383, ns; n = 4 for both) (Fig. 11).  Therefore, block of ICl,swell with EbO was 
downstream of H2O2 and these findings suggest both a common mechanism and 
common binding site.   
 
3.5.2  Thr101 
Thr101 is a NOX2-selective (Smith et al., 2012) congener of Ebs with a sulfur 
replacing selenium and an additional fluoride (F) and methyl (CH3-) group.  In contrast to 
Ebs but similar to EbO, Thr101 does not possess GPx activity (Leurs et al., 1989).  One 
might argue that block of ICl,swell by EbO in the previous experiment could be due to 
reduction of EbO back to GPx-mimetic Ebs by an unknown cellular processes. Therefore, 
to further challenge the importance of Ebs GPx mimetic activity in block of ICl,swell, we 
tested the ability of Thr 101 to block of ICl,swell despite the Se to S substitution and the 
response to exogenous H2O2 after block.  Because NOX2 is upstream from mitochondrial 
ROS production in the ICl,swell signaling cascade (Deng et al., 2010a), activation of ICl,swell 
by mitochondrial ROS is expected to bypass the effect of suppression of NOX2 by Thr101 
on ICl,swell. 
 
3.5.2(a)  Block of ICl,swell with Thr101 
Fig. 12 shows Thr101 blocked 86.2 ± 4.1% (n = 3, P < 0.001) of Diaz [in]-induced 
ICl,swell.  The kinetics of block by Thr101 was slow relative to Ebs (Ebs: 1.6 ± 0.3 min; 
Thr101: 23.1 ± 6.0 min; n = 5 for both; P < 0.001).  Moreover, Thr101 failed to washout 
after 25-55 min, and 90.4 ± 3.6% of the current remaining blocked (n = 3, P = 0.269; ns).  
Thus block of ICl,swell by Thr101 also appeared irreversible (Fig. 12).  This demonstrates 
that Se is not required and GPx-like activity were not required to irreversibly block ICl,swell.                                                                                                                                                                                                                     
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FIG. 11:  H2O2 failed to activate ICl,swell following block with EbO.  ICl,swell was 
activated with Diaz [in], blocked with 15 µM EbO, and EbO briefly washed out prior to 
adding H2O2.  Current traces (A) and I-V relationships (B) showing activation with Diaz 
[in] (green), block with EbO (red), washout of EbO (blue), and attempted activation with 
H2O2 (dark yellow).  C. Fractional block of Diaz-induced current (99.2 ± 14.0 pA/pF) 
by 15 M EbO, response to washout of EbO, and attempted activation of ICl,swell with 
H2O2.  EbO (15 M) blocked 93.1 ± 1.4% (n = 4, P < 0.001) of the current and failed 
to washout in 1T (n = 4, P = 0.471; ns).  Final treatment with H2O2 (500 M) also failed 
to recover ICl,swell compared to EbO block (n = 4, P = 0.186; ns) or washout (n = 4, P 
= 0.383; ns).  D. Time-course of experiment; time of break in indicated by open blue 
square. 
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FIG. 12:  Thr101 blocked ICl,swell and failed to washout.  ICl,swell was activated with 
Diaz [in] and was blocked with 15 M Thr101.  Current traces (A) and I-V relationships 
(B) showing activation with Diaz (green), block with 15 M Thr101 (red), and attempted 
washout with 1T bath solution (blue).  C. Fractional block of Diaz-induced current 
(102.5 ± 44.4 pA/pF) by 15 M Thr101 and attempted washout of Thr101.  Thr101 
blocked 86.2 ± 4.1% (n = 3, P < 0.001) of the current and failed to washout in 1T (n = 
3, P = 0.269; ns).  D. Time-course of the experiment; time of break in indicated by open 
blue square. 
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3.5.2(b)  Thr101 blocked downstream of H2O2 
 To determine if Thr101 blocked distal to H2O2, the effect of exogenous H2O2 (11-
52 min) following Thr101 inhibition was also tested (Fig. 13).  After blocking 83.8 ± 1.2%  
 (n = 3, P < 0.001) of Diaz [in]-induced ICl,swell, H2O2 failed to reactivate ICl,swell (vs. Thr101,   
P = 0.202, ns; vs. WO, P = 0.234, ns; n = 3 for both) and 86.5 ± 1.3% of current remained  
blocked (Fig. 13).  As shown for Ebs (Fig. 8) and EbO (Fig. 11), Thr101 (Fig. 13) blocked 
downstream of exogenous H2O2.  This implies that block of ICl,swell with Thr101 is likely to 
be independent of NOX2- and mitochondrial ROS generation.   
 
 
3.6  Mechanism of Block and Location of Binding Site 
The apparent irreversibility and chemistry of Ebs and its congeners raise the 
possibility that these compounds act by forming Se-S (Glass et al., 1988; Sakurai et al., 
2006) or S-S (Smith et al., 2012) bonds.  Therefore, we decided to use classic impermeant 
MTS reagents to probe for the existence of thiol groups critical for the function of ICl,swell. 
 
3.6.1  MTSES blocked ICl,swell 
When negatively charged MTSES (Dunten et al., 1993; Yang et al., 1996; Chahine 
et al., 1997) was added to the bathing media following activation of ICl,swell by Diaz [in], it 
blocked 81.5 ± 5.0 pA/pF (n = 3, P < 0.001) of the Diaz [in]-induced current (103.7 ± 11.3 
pA/pF), as shown in Fig. 14.  As expected for formation of a S-S bond by MTSES, block 
appeared to be irreversible upon washout of MTSES (8-37 min) in DI TNC1 astrocytes (n 
= 3, P = 0.233; ns).  These experiments used a much lower concentration of MTSES than 
is often employed (e.g., 3.33 mM; Qiu et al., 2014), and 110 M MTSES took >1 hr to 
fully suppress ICl,swell.  Nevertheless, this demonstrates that free -SH groups accessible 
from the bathing solution are necessary to generate ICl,swell but does not identify the 
responsible protein.  To confirm this requirement was not cell-line specific, we repeated 
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FIG. 13:  H2O2 failed to activate ICl,swell following block with Thr101.  ICl,swell was 
activated with Diaz [in], blocked with 15 µM Thr101, and washed out prior to H2O2 
treatment.  Current traces (A) and I-V relationships (B) showing activation with Diaz 
[in] (green), block with 15 M Thr101 (red), washout of Thr101 (blue), and attempted 
activation with H2O2 (dark yellow).  C. Fractional block of Diaz-induced current (145.0 
± 3.3 pA/pF) by 15 M Thr101, response to washout of Thr101, and attempted 
activation of ICl,swell with H2O2.  Thr101 (15 M) blocked 83.8 ± 1.2% (n = 3, P < 0.001) 
of the normalized current and failed to washout in 1T (n = 3, P = 0.708; ns).  Final 
treatment with H2O2 (500 M) also failed to recover ICl,swell compared to Thr101 block 
(n = 3, P = 0.202; ns) or washout (n = 3, P = 0.234; ns).  D. Time-course of the 
experiment; time of break in indicated by blue square.   
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FIG. 14:  MTSES blocked ICl,swell and failed to washout in DI TNC1 astrocytes.  
ICl,swell was activated in DI TNC1 astrocytes with Diaz [in] and was blocked with 
MTSES.  Current traces (A) and I-V relationships (B) showing break in (blue), 
activation with Diaz [in] (green), block with 110 M MTSES (red), and attempted 
washout in 1T (dark red).  C. Block of Diaz-induced raw current density (pA/pF) by 
MTSES and washout (WO).  MTSES (110 M) blocked 81.5 ± 5.0 pA/pF (n = 3, P < 
0.001) of the Diaz-induced current (103.7 ± 11.3 pA/pF) and failed to washout in 1T (n 
= 3, P = 0.233; ns).  D. Time-course for the experiment; time of break in indicated by 
blue square. 
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the study using the HEK293 cell line.  ICl,swell in HEK293 cells was activated by including 
the same concentration of Diaz in the patch pipette, and MTSES was then added to the 
bathing media.  As found for DI TNC1 cells, MTSES blocked 84.2 ± 5.7% (n = 3, P < 0.01) 
of Diaz [in]-induced ICl,swell in HEK293 cells (Fig. 15). 
   
3.6.2  MTSEA-biotin blocked ICl,swell 
Another commonly used MTS reagent in ion channel studies is MTSEA.  As 
MTSEA itself is uncharged and known to permeate the cell membrane, we used MTSEA-
biotin (Traebert et al., 2000; Wagner and Czajkowski, 2001), an impermeant biotinylated 
derivative of MTSEA that would simultaneously test the importance of charge on an MTS 
reagent and the possibility of streptavidin-assisted pull down of the target channel or 
regulatory protein.  Fig. 16 shows 82.5 ± 4.6% (n = 3, P < 0.001) block of Diaz [in]-induced 
ICl,swell with 30 M MTSEA-biotin.  As with MTSES (Fig. 14), block with MTSEA-biotin 
appeared irreversible following 26-63 min washout and 83.6 ± 3.7% of the current 
remained blocked (n = 3, P = 0.775; ns).  Time to full block was >1 hr with the low 
concentration of reagent.  Moreover, positively charged MTSET fully blocked ICl,swell and 
showed irreversibility upon washout (Appendix, Fig. 9).  The complete block of natively 
expressed ICl,swell by MTS reagents with different charge profile strongly suggests that a 
free -SH groups located extracellularly are required for current activation.  Although block 
was not strictly MTS charge-dependent, we did not assess how MTS charge affected the 
kinetics of block or its voltage dependence.  
 
 
3.7  Probing the Existence of Selenenylsulfide (Se-S) Bond with Reducing Agents 
 If free -SH groups with extracellular access are required for the activity of ICl,swell, 
then the best complimentary protocol to demonstrating block by Ebs, its congeners, and 
MTS reagents would be the use of specific reducing agents that can chemically cleave  
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FIG. 15:  MTSES blocked ICl,swell and failed to washout in HEK293 cells.  ICl,swell 
was activated in HEK293 cells with Diaz [in] and was blocked with MTSES.  Current 
traces (A) and I-V relationships (B) showing break in (blue), activation with Diaz [in] 
(green), and block with 2 mM MTSES (red).  C. Fractional block of Diaz-induced 
current (112.0 ± 68.8 pA/pF) by MTSES.  MTSES (2 mM) blocked 84.2 ± 5.7% (n = 3, 
P < 0.01) of the normalized current. 
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FIG. 16:  MTSEA biotin blocked ICl,swell and failed to washout.  ICl,swell was activated 
with Diaz [in] and blocked with MTSEA biotin prior to attempted washout (WO) in 1T.  
Current traces (A) and I-V relationships (B) showing break in (blue), activation with 
Diaz [in] (green), block with 30 M MTSEA Biotin (red), and WO with 1T (dark red).  C. 
Fractional block of Diaz-induced current (90.7 ± 15.2 pA/pF) by MTSEA biotin and WO.  
MTSEA biotin (30 M) blocked 82.5 ± 4.6% (n = 3, P < 0.001) of the current and failed 
to washout in 1T (n = 3, P = 0.775; ns).  D. Time-course for the experiment; time of 
break in denoted by filled blue circle. 
 
46 
 
Se-S or S-S bond to reactivate ICl,swell.  We used Ebs, the only molecule with nanomolar 
affinity for ICl,swell, to first block ROS-induced activation of current prior to attempting 
reactivation with specific reducing agents, DTT and GSH.    
 
3.7.1  DTT 
 Fig. 17 shows that following Diaz [in]-induced activation of ICl,swell, 15 M Ebs fully 
blocked 93.5 ± 1.0% (n = 3, P < 0.001) of the current, and 5 mM DTT applied for 15-20 
min duration failed to reactivate ICl,swell (vs. Ebs,  P = 0.220, ns; vs. WO, P = 0.895, ns; n 
= 3 for both) and 95.0 ± 0.4% of current remained blocked.  To explore alternatives, in 
the experiment illustrated, we also resorted to sequential superfusion of 1 mM (>20 min) 
and 5 mM (~20 min) impermeant GSH and then a membrane permeable version of GSH,   
GSH-MEE (n = 1).  After a total of ~130 min in various reducing, reactivation of the current 
did not occur.  
 
3.7.2  GSH 
To more rigorously test the ability of GSH to reduce the presumptive Se-S bond 
formed by Ebs, the experiment repeated challenging Ebs block of ICl,swell with 1 to 10 mM 
GSH (Fig. 18).  Following Ebs blocked of 93.8 ± 1.0% (n = 5, P < 0.001) of Diaz [in]-
induced ICl,swell, Ebs was briefly washed out from the bath (2-3 min)  and then GSH was 
superfused.  Near the end of 10 mM GSH superfusion (3-14 min), a small but statistically 
significant partial recovery ICl,swell after Ebs block was observed (vs. Ebs and WO,  P < 
0.01, n = 5 for both), although 89.0 ± 1.6% of the Diaz [in]-induced current remained 
blocked.  Because this apparent recovery occurred at the end of the experiment, it is 
difficult to exclude the possibility that the integrity of the gigaohm seal was becoming 
compromised. Nevertheless, it is clear that reducing agents DTT and GSH agents failed 
to vigorously reverse block of ICl,swell by Ebs.  Two possibilities to explain these 
observations should be considered.  First, it is possible that block of ICl,swell by Ebs does  
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FIG. 17:  DTT failed to activate ICl,swell following block with Ebs.  ICl,swell was 
activated with Diaz [in], blocked with 15 µM Ebs, and washed out briefly before DTT 
treatment in bath.  Current traces (A) and I-V relationships (B) showing activation with 
Diaz [in] (green), block with 15 M Ebs (red), washout (WO) of Ebs (blue), and 
attempted recovery with 5 mM DTT (dark yellow).  C. Fractional block of Diaz-induced 
current (240.9 ± 77.6 pA/pF) by Ebs, WO of Ebs, and recovery with DTT.  Ebs (15 M) 
blocked 93.5 ± 1.0% (n = 3, P < 0.001) of the current and failed to washout in 1T (n = 
3, P = 0.183; ns).  Attempted recovery with DTT (5 mM) failed to turn on ICl,swell 
compared to either Ebs block (n = 3, P = 0.220; ns) or washout (n = 3, P = 0.895; ns).  
D. Time-course for the experiment; time of break in denoted by dark open gray square.  
For this experiment (n = 1), different concentrations of Glutathione (GSH:  1 mM, cyan 
open square; 5 mM, cyan filled square) were added in bath following 5 mM DTT; none 
of the GSH treatments recovered ICl,swell including GSH-MEE (500 M) (membrane 
permeable derivative).   
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FIG. 18:  GSH failed to activate ICl,swell following block with Ebs.  ICl,swell was 
activated with Diaz [in], blocked with Ebs, and washed out briefly before GSSH 
treatment.  Current traces (A) and I-V relationships (B) showing activation with Diaz [in] 
(green), block with 15 M Ebs (red), washout (WO) of Ebs (blue), and recovery with 
10 mM GSSH (dark yellow).  C. Fractional block of Diaz-induced current (141.3 ± 20.9 
pA/pF) by Ebs, WO of Ebs, and recovery with GSH.  Ebs (15 M) blocked 93.8 ± 1.0% 
(n = 5, P < 0.001) of the current and failed to washout in 1T (n = 5, P = 0.838; ns).  
Attempted recovery with GSH (10 mM) partially recovered ICl,swell compared to either 
Ebs block (n = 5, P < 0.01) or washout (n = 5, P < 0.01).  D. Time-course for the 
experiment; time of break in denoted by filled blue square.  In this experiment, different 
concentrations of Glutathione (GSH:  1 mM, cyan open square; 5 mM, cyan filled 
square) were added in bath; only 10 mM GSH (dark yellow) appeared to elicit a slight 
recovery ICl,swell.    
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not involve a Se-S bond and there is nothing to reduce.  Second, if a Se-S bound is 
required, access to the bond may be restricted thereby limiting the ability of reducing 
agents to act.    
Because HEK293 cells were utilized in studies showing block by MTSES (Fig. 15), 
which is expected to be irreversible, we also wanted to characterize block of ICl,swell by 
Ebs in this cell line.  Fig. 19 shows that 15 M Ebs blocked 96.6 ± 0.9% (n = 3, P < 0.001) 
of Diaz [in]-induced ICl,swell in HEK293 cells.  In contrast to studies in the astrocyte cell 
line, after 11-36 min of washout a small but statistically significant recovery of current was 
observed, 6.7 ± 1.4% (n = 3, P < 0.05).  The mechanistic basis for partial recovery from 
Ebs block in this cell line was not explored.  
 
 
3.8  Topology of ICl,swell Block 
Although the nature of irreversible block by impermeant MTS reagents suggest 
that ICl,swell activation may involve free -SH groups located on the outside, it remains 
unclear whether Ebs functions in a similar manner from the outside or whether Ebs acts 
on cytosolic targets that critically modulate ICl,swell apart from its action as a GPx-mimetic.  
If Ebs acts at an intracellular binding site, adding Ebs directly to the cytosol would be 
expected to have equal or greater potency and faster kinetics of block than adding Ebs 
to the bath solution.  On the other hand, if Ebs and MTS reagents share a common binding 
site accessible from the extracellular face of the membrane, Ebs added to the cytosol 
might act with reduced potency and with slower kinetics because it would be more difficult 
for Ebs to reach its binding site.  To test this idea, we back-filled the patch pipette with 
Ebs (30 M; Ebs [in]) and activated DI TNC1 cells by osmotic swelling in 0.8T.     
 
3.8.1  Ebs blocked ICl,swell only from the outside 
Fig. 20 shows that inclusion of 30 M Ebs in the patch pipette (Ebs [in], inset),  
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FIG. 19:  Ebs blocked ICl,swell and failed to washout fully in HEK293 cells.  ICl,swell 
was activated with Diaz [in] and was rapidly blocked with 15 M Ebs prior to washout 
(WO).  Current traces (A) and I-V relationships (B) showing break in (blue), activation 
with Diaz [in] (green), block with 15 M Ebs (red), and WO (dark yellow).  C. Fractional 
block of Diaz-induced current (138.9 ± 10.4 pA/pF) by Ebs and WO of Ebs.  Ebs (15 
M) blocked 96.6 ± 0.9% (n = 3, P < 0.001) of the current and showed partial washout 
in Ebs-free 1T (n = 3, P < 0.05).  D. Time-course for the experiment; time course 
denoted by filled blue circle.       
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FIG. 20:  Ebs blocked ICl,swell only from the outside.  ICl,swell was activated with 0.8T 
with 30 M Ebs back-filled in pipette (Ebs [in]; see inset) and was blocked by 15 M 
external Ebs in 0.8T.  Current traces (A) and I-V relationships (B) showing break in 
(blue), activation with 0.8T (green), and block with 15 M Ebs (red) in 0.8T.  C. 
Fractional block of 0.8T-induced current (243.6 ± 52.1 pA/pF) by Ebs.  Ebs (15 M) 
blocked 86.3 ± 1.9% (n = 6, P < 0.001) of the current.  D. Time-course for the 
experiment; time of break in denoted by filled blue square.     
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twice the concentration shown to block from the outside, failed to block 0.8T-induced 
ICl,swell, and the swelling-induced current increased to ~112 pA/pF and was maintained 
without evidence of developing block.  As a positive control, we added 15 M Ebs to the 
bathing media in the continued presence of 30 M Ebs [in].  External Ebs rapidly induced 
86.3 ± 1.9% (n = 6, P <0.001) block of the swelling-induced current (Fig. 20).  Time to full 
block with extracellular Ebs was 1-2 min, as shown previously for the Diaz [in]-activated 
current. One might argue that Ebs [in] prevented 0.8T-induced ICl,swell from climbing 
higher.  This possibility is difficult to rigorously exclude.  Nevertheless, the mean current 
density of ICl,swell in Fig. 20 was 243.6 ± 52.1 pA/pF (30 M; Ebs [in]), greater by a factor 
of 7 than the swelling-induced current observed in the absence of Ebs [in], 33.3 ± 6.9 
pA/pF (Fig. 2). These data suggest that Ebs blocked ICl,swell only from the outside, 
analogous to the action of impermeant MTS reagents. Moreover, the data argue that 
cytosolic actions of Ebs as a GPx-mimetic and intracellular ROS scavenger are not 
required for block of ICl,swell.  In a preliminary experiment, back-filling the patch pipette 
with Thr101 (30 M; Thr101 [in]) also failed to suppress 0.8T-induced ICl,swell, whereas 
subsequent addition of external Thr101 (15 M) blocked ICl,swell in the same cell 
(Appendix, Fig. 10).  Ebs [in] affected ICl,swell in one condition (see Appendix, pp. 100-02). 
 
3.8.2  DCPIB blocked ICl,swell only from the outside 
Our findings indicate that Ebs and MTS-reagents block ICl,swell at a site accessible 
from the outside face of the membrane. This raises a question:  Does block by DCPIB, 
the most selective blocker of ICl,swell identified to date, occur with a similar topology and 
preferentially block from the outside?  On the other hand, DCPIB inhibits K+ channels 
with low PIP2 affinity by binding to PIP2 binding site on the inner face of the membrane 
(Deng et al., 2016), and block of ICl,swell by DCPIB is reversible, suggesting it acts by a 
mechanism distinct from Ebs and MTS-reagents.  To evaluate whether DCPIB displays 
sidedness of action, we tested the effect of directly applying 30 M DCPIB to the cytosol  
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by back-filling the pipette.  As shown in Fig. 21, DCPIB [in] (see inset) failed to suppress 
ICl,swell in 0.8T.  In contrast, bath superfusion of DCPIB (10 M; DCPIB) blocked 77.3 ± 
5.3% (n = 5, P < 0.001) of ICl,swell in 5-15 min in the same cells.  Although finding that 
DCPIB act with the same topology as Ebs and MTS-reagents is intriguing, the present 
studies do not provide evidence these two groups of compounds act at the same site.  
 
 
3.9  Synthesis and Functionality of Ebs-biotin 
 As the molecular entity responsible for eliciting ICl,swell has been controversial, we 
wanted to utilize the high affinity irreversible binding profile of Ebs to pull out binding site 
that regulates channel function.  This site might be a component of the pore forming 
channel, a channel subunit, or a regulatory protein downstream from the site of ICl,swell 
activation by H2O2. In addition to targeting -SH groups covalently (Sakurai et al., 2006), 
the Se in Ebs can serve as a unique spectroscopic marker (Aitkin et al., 2012) that fully 
inhibits the current at 45 nM, suggesting an IC50 of <5 nM.  Although the characteristic 
Ebs extinction coefficient 340 nm (340) is 5,000 M-1 cm-1 (Zhao et al., 2002), which may 
be useful for monitoring the oxidation state of Ebs and its substrates, spectroscopy by 
itself cannot be used to pull out the target of Ebs.  An alternative, commercially available 
MTSEA-biotin is less than optimal for streptavidin-assisted pull down of the target protein 
that regulates ICl,swell because block of ICl,swell by MTSEA-biotin occurs with slow kinetics 
suggesting a lower affinity than Ebs for its –SH group target.  
 
3.9.1  Organic synthesis of Ebs-biotin tag 
 With the assistance of Dr. Matthew C.T. Hartman (Dept. of Chemistry, VCU), we 
developed a biotin tagged Ebs compound (Ebs-biotin). Following synthesis of Ebs-p-yne 
(Appendix, Fig. 2) and verification of its structure by via 1H-NMR (Appendix, Fig. 3 and 
4), azide-alkyne Huisgen cycloadditon (click chemistry) of azido-PEG3-biotin to Ebs-p- 
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FIG. 21:  DCPIB blocked ICl,swell only from the outside.  ICl,swell was activated with 
0.8T with 30 M back-filled DCPIB (DCPIB [in]; see inset) and blocked with 10 M 
external DCPIB in 0.8T.  Current traces (A) and I-V relationships (B) showing break in 
(blue), activation with 0.8T (green), and block with 10 M DCPIB (red) in 0.8T.  C. 
Fractional block of 0.8T-induced current (131.2 ± 32.6 pA/pF) by DCPIB.  DCPIB [out] 
(10 M) blocked 77.3 ± 5.3% (n = 5, P < 0.001) of the current.  D. Time-course for the 
experiment; time of break in denoted by filled blue square.       
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yne was performed to synthesize Ebs-biotin (Appendix, Fig. 5). The final structure of Ebs-
biotin was then verified by MALDI-TOF, documenting an exact molecular weight (MW) of 
743.20 g mol-1 (Appendix, Fig. 6).   
 
3.9.2  Ebs-biotin demonstrated decreased affinity for ICl,swell 
 As drug properties tend to change following derivatization, it was critical to test 
whether Ebs-biotin retained the ability of Ebs to block ICl,swell at nanomolar concentrations. 
Because addition of pegylated biotin (azido-PEG3-biotin) (Appendix, Fig. 5) with click 
chemistry increased the MW of Ebs from 274.18 to 743.20 g mol-1 (Appendix, Fig. 6), 
Ebs-biotin might block ICl,swell with low affinity or not at all.  Preliminary experiment showed 
that ICl,swell elicited with Diaz [in], was fully blocked by adding 15 M Ebs-biotin to the 
bathing media (n = 2; data not shown) and that block was irreversible (n = 1; data not 
shown).  However, block by Ebs-biotin was slowed by a factor of ~20 compared to block 
by Ebs (1-2 min for full block by 15 M Ebs). This suggests that the affinity of Ebs for its 
target was substantially reduced by addition of the biotin tag, limiting the utility of Ebs-
biotin as a tool for selective protein isolation.  
 
 
3.10  Ebs-p-yne:  Alternative Tool for Identifying Molecular Entity Regulating ICl,swell 
 We also decided to closely analyze the penultimate compound, Ebs-p-yne, which 
has an additional ethynyl group (C≡C) placed on the para (p-) position of the benzene 
ring of Ebs (Appendix, Fig. 1).  The ethynyl group is the reactive site required for click 
chemistry.  Moreover, its addition to the benzene ring of Ebs alters the electron distribution 
and thereby may alter the chemistry responsible for Ebs forming covalent bonds with 
targeted –SH groups.   
 
3.10.1  Ebs-p-yne blocked ICl,swell with higher affinity than Ebs 
56 
 
In a preliminary study, we tested whether 150 nM Ebs-p-yne blocked ICl,swell.  After 
activating ICl,swell with Diaz [in], 150 nM Ebs-p-yne fully suppressed the current in <15 min 
and appeared to act much faster than 150 nM Ebs (n = 1 for both; data not shown).  
Therefore, we studied the kinetics of Ebs-p-yne at 5 nM, the predicted IC50 for Ebs.  Fig. 
22 demonstrates that 5 nM Ebs-p-yne successfully blocked 90.4 ± 1.7% (n = 3, P < 0.001) 
of Diaz [in]-elicited ICl,swell.  In one experiment, we were able to demonstrate block by 5 
nM Ebs-p-yne was irreversible with ~40 min of washout with 1T, and moreover, as for 
Ebs, ~25 min superfusion with H2O2 failed to reactivate the current.  The complete block 
of ICl,swell with 5 nM Ebs-p-yne suggests an apparent IC50 in the pM range. 
    
3.10.2  Determination of rate constant (K) of block 
We assessed the rate constants for block assuming 1:1 bimolecular pseudo-first 
order kinetics that binding to the receptor was proportional to block of current, and that 
block by Ebs and its congeners was irreversible over the time course studied.  Binding to 
the receptors (R) and proportional block of current (-I) by drug (D) can be described by: 
    k1          k2 
  →     
   R + D  ←  RD         R-D 
    k-1  
where k1 is the initial rate constant for block, k-1 is the reverse rate constant which is 
assumed to be near 0, and k2 is the rate constant for the irreversible process where RD 
goes to R-D.  For simplicity the overall rate constant of block, K, does not distinguish 
whether RD or R-D is responsible for blocking the current.  This gives:    
          -dI/dt = {K [D]} R  
           -1 = K [D]  
After fitting to a single exponential function, the time constants for block, , by 45 
nM Ebs and 5 nM Ebs-p-yne were 33.9 ± 6.6 and 28.9 ± 3.0 min, respectively, strikingly 
similar despite the 9-fold difference in drug concentrations.  The K values (in M-1 sec-1)  
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FIG. 22:  Block of ICl,swell by 5 nM Ebs-p-yne.  ICl,swell was activated by Diaz [in] and 
blocked by 5 nM Ebs-p-yne.  Current traces (A) and I-V relationships (B) showing 
activation with Diaz (green), block with 5 nM Ebs-p-yne (red), washout (WO) (blue), 
and attempted recovery with 500 M H2O2 (dark yellow).  C. The Diaz-induced current 
was 180.5 ± 62.2 pA/pF, and Ebs-p-yne (5 nM) blocked 90.4 ± 1.7% (n = 3, P < 0.001).   
D. Time-course for the experiment; time of break in denoted by filled blue square.  For 
this experiment (n = 1), H2O2 (500 M) addition following ~40 min washout with Ebs-
p-yne free 1T failed to recover ICl,swell.      
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were calculated for 45 nM Ebs and 5 nM Ebs-p-yne and are shown in Fig. 23.  Ebs blocked 
with a K of 1.2 x 104 M-1 sec-1 while Ebs-p-yne blocked with a K of 11.8 x 104 (vs. Ebs, P 
< 0.05; n = 3 for both).  Thus the K for Ebs-p-yne was 9.8-fold greater than that for Ebs.  
This surprising higher affinity of Ebs-p-yne is likely to make it useful as a tag for identifying 
the molecular entity that regulates ICl,swell.              
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FIG. 23:  Comparison of rate constants (K) of block for 45 nM Ebs and 5 nM Ebs-
p-yne.  The K for Ebs was 1.2 x 104, while that for Ebs-p-yne was 11.8 x 104 (n = 3, P 
< 0.05).  K was calculated based on pseudo-first order kinetics assuming 1:1 
irreversible binding and that binding was proportional to block of current.   
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CHAPTER 4 
DISCUSSION 
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4.1  Identification of High Affinity Binding Molecular Tag of ICl,swell  
 We have identified ebselen (Ebs), ebselen oxide (EbO), Thr101, and MTS 
reagents as irreversible blockers of ICl,swell.  We found several of these molecules to act 
at a site distal to H2O2, the most distal regulator of ICl,swell identified to date.  Nevertheless, 
we did not establish whether these agents directly blocked the channel protein, a 
regulatory subunit, or another regulator molecule downstream in the signaling pathway 
that activates ICl,swell.  Common mechanism in blocking ICl,swell most likely involves 
covalent modification of –SH groups which are critical for channel function.  More 
importantly, Ebs demonstrated fast kinetics in blocking ICl,swell relative to activation than 
what has been previously reported by Deng et al. (2010a).  Ebs was also the fastest acting 
in blocking ICl,swell among all agents tested.  We showed complete block of ICl,swell using 
45 nM Ebs in addition to demonstrating that Ebs blocks ICl,swell irreversibly at a site distal 
to H2O2.  Furthermore, this predicts the IC50 of Ebs as <5 nM and suggests that Ebs may 
be a useful tool to identify the molecular basis of ICl,swell.  Therefore, we synthesized a 
novel congener of Ebs known as ebselen-para-yne (Ebs-p-yne) with the help of Dr. 
Matthew C.T. Hartman (Dept. of Chemistry, VCU) to pull out the genetic basis behind 
ICl,swell.  To our surprise, Ebs-p-yne demonstrated an even higher affinity in blocking 
ICl,swell with an apparent IC50 ~pM range where K for Ebs-p-yne was 9.8-fold greater than 
that for Ebs.  Ebs-p-yne is likely to be an important tool because tags can be directly 
attached to the molecule via standard click chemistry approaches.  Although biotinylated 
Ebs (Ebs-biotin) and biotinylated MTS reagent (MTSEA-biotin) also inhibited ICl,swell and 
were considered as useful tools, both molecules displayed slower blocking kinetics and 
lower apparent affinity for ICl,swell than Ebs and Ebs-p-yne.                   
Prior to synthesizing Ebs-p-yne, Ebs persistently demonstrated high affinity block 
of ICl,swell, which turned out to be irreversible and downstream of H2O2, the most 
proximate regulator of ICl,swell.  Based on reported claims that Ebs mainly functions in the 
scavenging of intracellular ROS, we decided to test EbO and Thr101, specific congeners 
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of Ebs lacking glutathione peroxidase (GPx) activity.  To our surprise, these congeners 
completely suppressed the ROS-sensitive current.  As with Ebs, the block was irreversible 
and downstream of H2O2.  These observations led to the premise that Ebs and its 
congeners must be sharing a common mechanism irrespective of GPx profile.  And based 
on structural chemistry of these molecules, we additionally proposed that Ebs and its 
congeners might function as sulfhydryl reagents.     
To validate this proposal, we decided to bath perfuse classic membrane 
impermeant MTS reagents (MTSES and MTSEA biotin) following diazoxide-induced 
activation of ICl,swell.  Both classic sulfhydryl reagents were fully capable of irreversibly 
suppressing the Cl- current in native DI TNC1 astrocytes at much lower concentration 
than what is normally reported (Qiu et al., 2014).  This was completely antithetic to earlier 
work by Qiu et al. (2014) involving SWELL1 (LRRC8A), the latest entity identified as 
ICl,swell, in which superfusion of 3.33 mM MTSES fails to suppress SWELLL1 after 
hyposmotically challenging their wild-type.  The MTS-induced suppression of ICl,swell in 
our experiments compared to Qiu et al. (2014) suggests an external binding site involving 
covalent modification of surface -SH moieties leading to disulfide (S-S) formation.  We 
also have preliminary data with MTSET and NEM both demonstrating fully irreversible 
inhibition of ICl,swell following current activation.  Although the use of two specific reducing 
agents (DTT and GSH) failed to demonstrate the preexistence of the selenenylsulfide 
(Se-S) bond upon Ebs-induced block of ICl,swell, it is foreseeable that access to the bond 
may be restricted thereby limiting the ability of reducing agents to reactivate ICl,swell.  In 
order to validate an external binding site and preclude the ROS quenching capability of 
Ebs as the primary cause of current suppression, we decided to directly expose the 
cytosolic compartment with Ebs by back-filling while under persistent hyposmotic 
challenge.  As predicted, Ebs was inert from the inside since 0.8T-induced ICl,swell 
persistently activated in the presence of intracellular Ebs.  Only exogenously applied Ebs 
was able to rapidly suppress ICl,swell.  We also tested DCPIB, the most selective blocker 
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of ICl,swell structurally unrelated to either Ebs or MTS reagents, and found that DCPIB also 
blocked solely from the outside.  External topological binding site seems to be required in 
block of ICl,swell.   
And based on the rate constant (K) of block for Ebs relative to ICl,swell and inability 
to washout downstream of H2O2, we synthesized a biotinylated derivative of Ebs (Ebs-
biotin) with the intention of directly pulling out the channel or channel component 
responsible for the current via streptavidin-assisted pull down.  Nonetheless, biotinylation 
caused a major loss of affinity toward ICl,swell.  This led us to evaluate Ebs-p-yne, an 
intermediate in the synthesis of Ebs-biotin.  To our surprise, we discovered that Ebs-p-
yne possesses an even higher affinity than Ebs thus allowing complete block at 5 nM.  
Upon calculating the K value of Ebs-p-yne, we surprisingly discovered that Ebs-p-yne 
demonstrates 9.8 fold greater affinity for ICl,swell compared to Ebs even when exogenous 
concentration employed was 9 fold less in block of ICl,swell.   
 
 
4.2  Functional Mechanism of Ebselen and Its Congeners 
4.2.1  Current knowledge about functional mechanism 
 Ebs has long been accepted to function primarily as a GPx-mimetic by diffusing 
through the cell membrane and functioning as a scavenger of ROS (Mϋller et al., 1984; 
Wendel et al., 1984; Sies and Masumoto, 1997; Nakamura et al., 2002; Deng et al., 
2010a, 2010b).  This selenium containing molecule is reported to decrease oxidative 
damage in tissues by reducing H2O2 and other hydroperoxides (Schewe, 1995).  
Cotgreave et al. (1989) reported IC50s ~20-50 M in neutrophils for blocking superoxide 
generation.  Others reported that Ebs inhibits PKC at 20 M in guinea pig alveolar 
macrophages (Leurs et al., 1989; Wakamura et al., 1990).  In contrast, Ebs can inhibit 
purified PKC from broken cell preparations at sub-micomolar concentrations (Cotgreave 
et al., 1989).  Therefore, Ebs also is implicated in preventing NOX2 assembly that involves 
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PKC-mediated phosphorylation of p47phox.  Smith et al. (2012), on the other hand, claim 
that Ebs disrupts the binding of the bis-SH3 domain of p47phox to the PRD (proline-rich 
domain) of p22phox.  Nonetheless, our experiments demonstrating Ebs as a sulfhydryl 
reagent and the ability of Ebs to block ICl,swell only from the outside will set out to argue 
against the relevance of these aforementioned mechanisms.         
The first congener of Ebs that we chose to test is EbO.  EbO can be readily 
produced when Ebs is oxidized in the presence of H2O2 (Glass et al., 1988); in addition, 
Sies and Masumoto (1997) mention EbO as a byproduct of reacting Ebs and peroxynitrite 
(ONOO-).  EbO is, therefore, cited in the literature as the most oxidized congener of Ebs 
(Glass et al., 1988; Daiber et al., 2000) and further oxidation is not possible under normal 
physiological condition.  As a result, EbO is characterized as lacking the ability to 
scavenge ROS (Lass et al., 1996).  Ultimately then EbO fails to demonstrate GPx activity, 
is inert to further cellular processes, and only occurs following the aftermath of quenching 
reactive oxygen species or reactive nitrogen species.  Although mechanistically unknown 
at this time, EbO could by some unexplored mechanism end up reverting back to Ebs.  
Nevertheless, we are not aware of such reversion taking place under normal cellular 
processes.   
Thr101 is the other congener of Ebs tested which contains sulfur (S) in place of 
selenium (Se) having additional fluoride (F) and ortho (o-) positioned methyl (CH3-) group 
on the benzene ring of the molecule.  Both S and Se belong to the chalcogen family on 
the periodic table with equal electronegativity values and share similar atomic property 
that often allows interchangeability in various biophysical uses.  Thus, even if S replaces 
Se as part of the structural backbone, Thr101 is still classified as part of the Ebs family of 
drugs.  Nevertheless, it is this Se to S substitution which disqualifies Thr101 as a GPx-
mimetic (Leurs et al., 1989; Smith et al., 2012).  However, this unique property of Thr101 
allows the drug to share the same pharmacological profile of Ebs while failing to function 
in scavenging of ROS.  Moreover, Thr101 can also target NOX2 by disrupting the 
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interaction of the bis-SH3 domain of p47phox to the PRD of p22phox as described for Ebs 
(Smith et al., 2012).  Smith et al. (2012) also point out that Thr101 demonstrates higher 
selectivity for NOX2 compared to Ebs.   
  
4.2.2  Alternative classification of Ebs and its congeners as sulfhydryl reagents  
 As mentioned, H2O2 has been characterized as the most distal in the ICl,swell 
signaling cascade being downstream of NOX and mitochondrial ROS production (Deng 
et al., 2010a).  This is clearly shown by Deng et al. (2010a) in freshly prepared rabbit 
ventricular myocytes.  Even though the exact ICl,swell regulatory cascade was never fully 
explored in DI TNC1 astrocytes as in the heart, our use of diazoxide and ability to turn on 
the current with exogenous H2O2 suggest that similar ICl,swell signaling cascade seems 
intact in DI TNC1 astrocytes.   
Whether Ebs works through scavenging of ROS or inhibiting NOX, exogenous 
H2O2 should have reactivated ICl,swell downstream of block by Ebs after the current is 
elicited.  As for EbO, the inert nature of the molecule toward further oxidation should have 
resulted in persistent demonstration of ICl,swell following activation.  However, both 
molecules behaved quite contrary to what was predicted.  For Ebs, H2O2 was incapable 
of reactivating the current.  On the other hand, EbO demonstrated full suppression of the 
current rather than being inert toward blocking ICl,swell.     
Experiments with Thr101 is more complicated and requires more explanation.  
Because Thr101 shares the pharmacological profile of both Ebs and EbO, intervention by 
Thr101 should disrupt NOX2 assembly while demonstrating inability to scavenge ROS 
after eliciting ICl,swell.  Assuming ICl,swell regulatory cascade mentioned is intact in DI TNC1 
astrocytes as in Deng et al. (2010a), this dual nature of Thr101 should lead to overall 
suppression of ICl,swell but eventual reactivation with exogenous H2O2 if Thr101 blocks 
upstream of ROS and functions according to its classical nature.  While Thr101 
demonstrated complete block of ICl,swell, superfused H2O2 failed to re-elicit the ROS-
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sensitive current thereby placing Thr101 distal to H2O2 regulation.  The block by Thr101 
also served to complimentarily validate EbO data.              
Although Ebs had the highest apparent affinity as an inhibitor of ICl,swell of the three 
molecules tested demonstrating an estimated apparent IC50 <5 nM, all three molecules 
blocked ICl,swell irreversibly and downstream of H2O2.  In view of the apparent high affinity 
of Ebs, we searched the literature looking for potential targets with nanomolar affinity.  We 
performed a detailed search of PubChem public database of chemical molecules 
(http://pubchem.ncbi.nlm.nih.gov) (search performed on June 25, 2016) and hit a total of 
327 bioactivity profiles for Ebs.  Top ten highest affinity targets of Ebs from this search 
are listed in TABLE 1 in the order of decreasing affinity.  Interestingly, none of the 10 
listed are extracellular in origin including UDP-glucose 4-epimerase, which is a validated 
drug target for African sleeping sickness (Urbaniak et al., 2006) with the highest binding 
affinity documented with an IC50 of 14 nM (TABLE 1).   
We also identified two specific bacterial targets of Ebs not included as part of the 
PubChem list.  First one identified is antigen 85 complex (Ag85c) (Favrot et al., 2013).  
According to Favrot et al. (2013), Ag85c in Mycobacterium tuberculosis is an emerging 
drug target where Ebs can covalently modify cysteine (C209) residue near the active site, 
therefore, leading to a covalent Se-S bond formation (Appendix, Fig. 7) with an observed  
Ki of 63 nM.  Others have also reported such cysteine-targeted modification of thiols (-
SH) by Ebs (Sakurai et al., 2006; Hanavan et al., 2015).  Second is the cysteine protease  
domain (CPD) within the Clostridium difficile major virulence factor toxin B (TcdB) (Bender 
et al., 2015).  Both bacterial paradigms report nanomolar binding affinities with IC50 ~100 
nM for Ag85c (Favrot et al., 2013) and IC50 ~6.9-17.2 nM for TcdB (Bender et al., 2015).   
We then theorized that irreversibility of Ebs and its congeners following block of 
ICl,swell results from direct covalent modification of -SH groups on the channel or channel 
component responsible for the current.  There are also reports of EbO-mediated rapid 
modification of -SH groups (Glass et al., 1988).  For Thr101, very little information exists  
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  TABLE 1 
IC50s and Potencies for Targets of Ebselen 
Activity [nM]                               Target 
IC50 14 UDP-glucose 4-epimerase 
Potency 63 15-lipoxygenase, partial 
Potency 71 euchromatic histone-lysine N-methyltransferase 2 
Potency 79 cytochrome P450 2C9 precursor 
IC50 111 PE/PC phosphatase isoform 1 
Potency 126 aldehyde dehydrogenase 1 family, member A1 
Potency 126 cytochrome P450 2C19 precursor 
IC50 190 MPI protein (phosphomannose isomerase type I) 
Potency 224 aldehyde dehydrogenase 1 family, member A1 
Potency 251 histone acetyltransferase KAT2A 
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regarding its mechanism other than disruption of bis-SH3 domain of p47phox to the PRD 
of p22phox as mentioned in Smith et al. (2012).  No mechanism is ever proposed.  
However, other than additional F- and CH3-groups on Thr101, structurally the molecule 
is very similar to Ebs although Se is replaced by elemental S in Thr101.  Furthermore, 
both Se and S belong to the chalcogen family of electron acceptors having the same 
number of outer shell valence electrons including identical electronegativity (Χ) values of 
roughly ~2.6 where Χ = 4.0 for F serves as a reference for being the most electronegative.  
Both chalcogens are often interchangeable during X-ray crystallography techniques.  
Based on such fact, we also proposed the existence of a Thr101-mediated covalent 
modification of -SH groups leading to disulfide (S-S) linkages and therefore, we 
postulated that Ebs, EbO, and Thr101 function as sulfhydryl reagents in blocking ICl,swell.   
To verify this proposal, we decided to probe the existence of free -SH groups with 
use of classic sulfhydryl group modifying MTS reagents often used in ion channel 
physiology following SCAM (Akabas, 2015).  The fact that cell impermeable MTS 
reagents demonstrated complete irreversible block regardless of charge on the MTS 
strengthens the idea that ICl,swell is modulated by extracellular -SH groups.  Unfortunately 
use of reducing agents such as DTT or GSH on Ebs did not demonstrate current recovery 
following block of ICl,swell with Ebs.  First possible reason for this inconsistency may be 
that as channels are embedded in membranes, these covalent modifications may not be 
fully accessible to various reducing agents once the bond forms and enters a hydrophobic 
pocket.  Second possibility is that the channel or channel component responsible for 
eliciting ICl,swell becomes internalized following covalent modification by Ebs and 
congeners.  Garlid et al. (2009) describing cardioprotective signaling to mitochondria 
proposes such a mechanism involving ligand-activated G protein-coupled receptor 
internalization as part of multimeric signaling complexes gathered in caveolae.  Third and 
final possible reason for this inconsistency may be that these covalent modifications really 
do not exist.  In addition, we have further evidence from ongoing studies by Belkhayat et 
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al. (2016, Unpublished Data) from our laboratory that N-Ethylmaleimide (NEM), an 
organic molecule derived from maleic acid containing an imide functional group used 
commonly for modification of cysteines in proteins and peptide fragments, can also block 
ICl,swell irreversibly downstream of H2O2.         
Clearly the evidence for cysteine-targeted thiol modification by Ebs and its 
congeners is very strong based on MTS data while failed recovery attempts with reducing 
agents might simply involve access issue.  This covalent modification would most likely 
serve as plausible explanation for why drug-free bathing media could not wash Ebs or its 
congeners off its intended target.  While the actual site of action for H2O2-induced ICl,swell 
is currently unknown, H2O2 is, nonetheless, a relatively strong cell permeable low 
molecular weight oxidizing agent capable of penetrating areas not normally accessed by 
larger molecules such as DTT or GSH.  Since H2O2 does not oxidize preexisting covalent 
bonds, failed attempts to elicit ICl,swell with exogenous H2O2 following block with Ebs and 
its congeners may be redox-related desensitization.  To recapitulate, the fact that Ebs, 
EbO, and Thr101 along with MTS reagents all commonly demonstrate complete 
irreversible block of ICl,swell strongly support the idea that these three molecules may be 
functioning as sulfhydryl modifying agents.    
 
4.2.3  Topology:  Ebs failed to block ICl,swell from the inside  
While ample evidence points to thiol-modified irreversible covalent bond formation 
from the outside, we could not with certainty preclude possible intracellular effects of 
these molecules because Ebs and its congeners are described as being cell permeable 
(Glass et al., 1988; Leurs et al., 1989; Schewe, 1995; Lass et al., 1996; Daiber et al., 
2000; Zhao et al., 2002; Sakurai et al., 2006; Deng et al., 2010a; Aitken et al., 2012; Smith 
et al., 2012).  When Ebs failed to block ICl,swell from the inside in back-filling experiments, 
we searched the literature seeking measurements of Ebs permeability.  Aitken et al. 
(2012) discussed the effective use of the Se atom of Ebs as a traceable isotopic marker.  
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According to Aitken et al. (2012), Se is a trace element having multiple isotopes found 
only in extremely low concentrations in cultured cells.  Taking this isotopic approach, 
Aitken et al. (2012) based on evidence from synchrotron radiation induced X-ray emission 
(SRIXE) spectroscopy mapping of Ebs mention that only small traces of Se corresponding 
to drug uptake eventually localize to a discreet region of the cell after 1 h in differentiated 
ND15 cells.  Rather than accumulation of intracellular Ebs within the timeframe coinciding 
with the block of ICl,swell normally observed < 2 min, results by Aiken et al. (2012) raise 
the implication that Ebs might not be as permeable.  In addition, Aiken et al. (2012) point 
to unexplained total dissipation of intracellular Ebs content following 4 h in ND15 cells not 
only casting doubt regarding the intracellular role of Ebs but also raising suspicion of its 
permeability.  Irrespective of whether Ebs is found in its free form or bound to a specific 
target inside the cell, the X-ray methodology utilized by Aitken et al. (2012) should have 
detected the elemental Se of Ebs.     
The fact that direct cytosolic exposure to Ebs (Ebs [in]; 30 M) failed to block the 
current under constant hyposmotic challenge (0.8T) while demonstrating complete block 
of ICl,swell <2 min with superfused Ebs (Ebs [out]; 15 M) clarifies the presumption that 
both Ebs and MTS reagents share an external binding site and similar mechanism of 
action.  If block was truly diffusion-limited, then immediate exposure of the cytosol to Ebs 
in back-filling studies should have resulted in rapid suppression of ICl,swell despite the 
ability of Ebs to function as a scavenger of ROS or an inhibitor of NOX.  Despite the 
property of Ebs ultimately responsible, an immediate block of ICl,swell from the inside would 
have strongly argued in support of the canonically accepted intracellular functionality of 
the molecule.  We also have evidence that Thr101 failed to block ICl,swell from the inside 
while under hyposmotic challenge (n = 1).  While the SRIXE study of Ebs does provide 
incontrovertible evidence that Ebs permeates through the cell membrane albeit slowly ~1 
h (Aitken et al., 2012), the inability to block ICl,swell from the cytosolic side as we 
demonstrated irrefutably also support the idea that Ebs topologically blocks from the 
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outside.  Nonetheless, Ebs appears to demonstrate limited-diffusivity according to Aitken 
et al., 2012.  Multiple connotations (Mϋller et al., 1984; Wendel et al., 1984; Glass et al., 
1988; Leurs et al., 1989; Schewe, 1995; Lass et al., 1996; Sies and Masumoto, 1997; 
Daiber et al., 2000; Nakamura et al., 2002; Zhao et al., 2002; Sakurai et al., 2006; Deng 
et al., 2010a; Aitken et al., 2012; Smith et al., 2012) to Ebs as a fully membrane permeable 
molecule might, therefore, be slightly misleading.  Furthermore, Ebs has mostly been 
used in cell-free condition (Zhao et al., 2002; Smith et al., 2012) where diffusion through 
the membrane becomes irrelevant.  With permeability aside, our aforementioned data 
clearly indicate that Ebs-induced block of ICl,swell undeniably takes  place topologically 
from the outside and completely lacks function from the inside under intact whole cell 
patch-clamp parameter.        
With inability of Ebs to demonstrate block from the inside, question was also raised 
regarding DCPIB topology in blocking ICl,swell.  The fact that DCPIB failed to block ICl,swell 
from the inside while mirroring the effect of Ebs from the outside, points to the importance 
of outer topology in the mechanism of block.  As DCPIB cannot function as a sulfhydryl 
reagent, we cannot make the claim that DCPIB and Ebs share a common mechanism nor 
a common binding site.  But it is critical to mention that both binding sites are located on 
the outside.  DCPIB is also a butanoic acid derivative having a carboxylic acid 
functionality.  Under physiological pH 7.4, the acidic proton becomes deprotonated and 
the molecule becomes negatively charged.  It is well known that charged molecules have 
difficulty crossing the cell membrane unless traversed in through an ion channel or 
somehow transported inside.  Based on this alone, DCPIB most likely works from the 
outside as our back-filling data seem to suggest.  This outer topology is in stark contrast 
to inwardly rectifying K+ (Kir) channels with weak affinity for PIP2 (Deng et al., 2016).  
Deng et al. (2016) mentions that DCPIB can directly compete for PIP2 binding site as long 
PIP2 interaction is relatively weak compared to Kir channels demonstrating higher PIP2 
binding affinity.  Thus, as long as PIP2 is bound relatively weak, then DCPIB must 
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compete with PIP2 from the cytosolic side.  Since we are dealing with two completely 
different channels that pass ions of the opposite charge, both binding topologies are likely 
to be correct as DCPIB can have off-target effects other than selective inhibition of ICl,swell.  
In fact, recent publication on DCPIB pharmacology validates some of these off-target 
effects of DCPIB.  According to Bowens et al. (2012), several glutamate transport 
pathways in glial cells are sensitive to block by DCPIB.  In rat glial cells, for instance, 
DCPIB can potently inhibit glutamate release through connexin hemichannels (Cx43) and 
glutamate uptake via the glutamate transporter (GLT-1).  Although topology of block is 
never mentioned in Bowens et al. (2012), evidence for such non-ICl,swell targets certainly 
lends credibility to DCPIB- PIP2 competition in Kir channels.  Additional studies will be 
needed prior to drawing any conclusion regarding DCPIB, but it is clear at the moment 
that DCPIB is the most selective for inhibition of ICl,swell under patch clamp conditions that 
isolate the anionic currents.  As DCPIB can competitively knock off PIP2 from its binding 
site in certain Kir channels, it is not far-fetched to postulate the effect of PIP2 on ICl,swell.  
While our lab has not studied this issue, Yamamoto et al. (2008) have suggested PIP3 as 
the key important player in restoring ICl,swell where PIP2 mainly functions as a substrate 
of PI-3K for generating PIP3.  The fact that DCPIB blocked only from the outside, although 
in sharp contrast to Kir channels with weak affinity for PIP2, offers more assurance for 
Ebs blocking only from the outside and more importantly demonstrates that topological 
preference in block of ion channels is not unique to ICl,swell.   
 
 
4.3  Implications for SWELL1 (LRRC8A) 
SWELL1 (Qiu et al., 2014) or LRRC8A (Voss et al., 2014) was originally identified 
through the use of a high-throughput cell-based fluorescence assay screening for ICl,swell 
activity in HEK293T cells persistently expressing the halide (I-)-sensitive yellow 
fluorescent protein (YFP) in accompaniment with genome-wide RNAi screen ultimately 
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using swelling as the primary stimulus for activating ICl,swell.  Out of 17,631 known and 
4,837 predicted human genes, choice was narrowed down to 51 candidates before 
identifying SWELL1 siRNA as the most likely candidate responsible for ICl,swell based on 
I- quenching response in the presence of DCPIB (Qiu et al., 2014).  When HeLa cells 
expressing stable SWELL1 knockdown were co-transfected with RNAi-insensitive wild-
type (WT) SWELL1, bath applied MTSES (0.1-3.33 mM) failed to block hyposmotically 
elicited ICl,swell.  It was only through systematically placing T44C mutation into 
transmembrane domain (TMD) 1 of LRRC8A via SCAM that the candidate entity 
responded to ~20% block with MTSES following hyposmotic challenge.  This was 
completely opposite to our MTSES data.  Our results demonstrated that MTSES was fully 
capable of inhibiting the native current at a set concentration of 110 M compared to a 
wider concentration range required of SWELL1.  There may be several plausible 
explanations for such inconsistency.  First and foremost, current elicited by SWELL1 may 
not explicitly be identical to what is measured in native DI TNC1 astrocytes.  While DCPIB 
suppressed SWELL1 with an IC50 of 20.9 M, normally complete suppression of ICl,swell 
can be achieved at 10 M with our protocol which places the IC50 ~1-2 M much closer 
to values reported in literature; therefore, at a concentration 10-20 fold greater, DCPIB 
can foreseeably bind to other targets similarly to what Bowens et al. (2013) and Deng et 
al. (2016) have reported.  Second explanation is that different stimuli activate completely 
different Cl- currents.  While hyposmotic media was used to activate the current in HeLa 
cells, our work utilized intracellular diazoxide for directly eliciting ICl,swell proximate to the 
source independent of swelling-activated regulatory cascade.  Although the work in 
cardiac myocytes by Deng et al. (2010a) shows a serial relationship of swelling-induced 
mitochondrial ROS release that elicit ICl,swell, this was never explored in HeLa cells by Qiu 
et al. (2014) whereas we demonstrated direct activation of ICl,swell with exogenous H2O2 
which was fully blocked by DCPIB in DI TNC1 astrocytes in addition to hyposmotically 
activating the current followed by block with DCPIB in the same cell line.  Final reason for 
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the disparity might be the existence of multiple unidentified ICl,swell isoforms giving rise to 
ICl,swell not to mention variations that might even exist within single cell type.  Therefore, 
the differences may arise from off-target effects of agents used to characterize the 
current, ICl,swell signaling cascade, and variable isoforms from cell type to cell type.  
Nonetheless, as MTSES also provided complete inhibition of intracellular diazoxide-
induced ICl,swell in native HEK293 cells, the cell type argument is yet to hold. 
Perhaps the biggest inconsistency for SWELL1 is the lack of inhibition by MTSES 
for WT SWELL1 in contrast to complete inhibition of ICl,well with three different MTS 
reagents in DI TNC1 astrocytes.  The fact based on responses to MTSES is clear in that 
non-selective ICl,swell modulatory components are likely involved as our data point to; 
however, inability to demonstrate any response to MTSES in SWELL1 clearly remains 
problematic and deserves a second look.  It is also noteworthy to mention that 
overexpression of WT SWELL1 does not lead to more current.  Qiu et al. (2014) 
contributes this phenomenon to the existence of multiple subunits where only proper 
assembly of the multimeric channel can elicit ICl,swell.  We, nevertheless, have preliminary 
data showing that siRNA directed against SWELL1 failed to substantially knockdown 
ICl,swell in DI TNC1 astrocytes implicating that SWELL1 might not be the true molecular 
identity responsible for modulating ICl,swell; however, at the same time we cannot preclude 
the involvement of different ICl,swell subunits currently unknown to us that might be a 
critical factor in eliciting ICl,swell.     
 
 
4.4  Significance and Future Studies 
 The novel property of Ebs-p-yne with its predicted IC50 ~pM along with its 
sulfhydryl modifying property based on the parent compound Ebs opens the door for the 
first time to perform unique click chemistry reactions while serving as a blocker of ICl,swell 
with the highest affinity ever reported to date.  Although selectivity of Ebs-p-yne was not 
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explored in detail, we have evidence at least in Xenopus oocytes that calcium-activated 
chloride channels are unaffected by Ebs (n = 4; data not shown).  Moreover, pM binding 
affinity tends to be very selective as shown in certain bacterial toxins such as the cholera 
toxin in its ability to bind cerebral gangliosides (Kuziemko et al., 1996).  While the 
usefulness of Ebs-biotin originally intended for streptavidin-assisted pull down of ICl,swell 
or channel component is yet to be elucidated from what can only be characterized as loss 
of high affinity toward ICl,swell following biotinylation, Ebs-p-yne, on the other hand, may 
be used in biotin/streptavidin-free click chemistry reactions where alkyne-tagged proteins 
may be eluded directly off azide-columns.  Furthermore, fluorescent tags can now be 
directly attached to Ebs-p-yne to be studied in confocal imaging under various 
pathological models.  As Ebs is currently in clinical trials and under investigation as a 
treatment for reperfusion injury, stroke, bipolar disorder, traumatic brain injury (TBI), 
cancer, and bacterial infections, the higher affinity of Ebs-p-yne over the parent 
compound has tremendous implications on all of these disease states.   
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FIG. 1:  Structures of Ebs and its congeners 
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FIG. 2:  Steps for organic synthesis of Ebs-p-yne (Hartman Lab). 
Step 1: Antranillic acid was first dissolved in water.  HCl was then added and cooled 
down to -18 ˚C for proper formation of nitronium ion, which only exists below -15 ˚C.  
Once properly cooled, addition of sodium nitrate dissolved in water lead to nitronium 
ion generation.  Using Rongalite and NaOH, the solution was then made basic for 
stabilizing diselenide species.  The reaction mixture was stirred under reflux for 1 h.  
The mixture was then reacidified and the precipitate was filtered prior to redissolving 
under basic condition.  This basic mixture was once more filtered and made acidic prior 
to final filtration.  The intermediate (67% yield) compound was then obtained from hot 
ethanol. 
         
Step 2: Thionyl chloride was added as solvent/reagent, refluxed for 3 h under inert 
condition, and removed under decreased pressure.  The remaining solid was then 
crystalized with hexanes to generate a chlorinated intermediate (82% yield). 
       
Step 3: This chlorinated intermediate was then dissolved in CCl4 and corresponding 
2-, 3-, or 4-Ethynylaniline dissolved in CCl4 was added using a syringe.  Final mixture 
was stirred for ~45 min  1 h before purifying via column chromatography.  For 
generating Ebs-p-yne [para (p)-Ebs derivative] with a 26% yield, 4-Ethynylaniline/ CCl4 
was added.  Adding either 2-Ethynylaniline or 3-Ethynylaniline would analogously lead 
to Ebs-o-yne (ortho) or Ebs-m-yne (meta) derivatives, respectively.          
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FIG. 3:  1H-NMR spectrum of Ebselen (Ebs) prior to derivatization (Hartman Lab).  
Structure of Ebs is shown as reference along with five specific peaks each with 
appropriate splitting.  Prior to derivatization, chemical shift at 7.3 ppm (triplet) due to 
proton (red circle) on the para position of benzene ring of Ebs each split by adjacent 
protons (blue circles) is noticeably prominent.    
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FIG. 4:  1H-NMR spectrum of Ebs-p-yne (Hartman Lab).  Upon adding 4-
Ethynylaniline to last step of synthesis, prominent chemical shift at 7.3 ppm (missing 
triplet) normally observed in Ebs disappeared with the appearance of an ethynyl proton 
(red circle) peak at 4.2 ppm.   
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FIG. 5:  Huisgen cycloaddition (click chemistry) of azido-PEG3-biotin and Ebs-p-
yne for synthesizing Ebs-PEG3-biotin (Ebs-biotin) (Hartman Lab).  
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FIG. 6:  Matrix-assisted laser desorption/ionization-Time of flight (MALDI-TOF) 
(Hartman Lab).  Proper synthesis of Ebs-PEG3-Biotin was verified showing an exact 
mass of 743.20 Daltons.  Due to existence of various selenium isotopes found in 
nature, multiple peaks were found and are shown on the right (742.3008; 743.2949; 
744.2998).   
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FIG. 7:  Thiol-mediated nucleophilic attack of Ebs.  Free -SH groups can directly 
attack the Se of Ebs leading to the formation of S-Se bond as shown.  The figure has 
been adapted from Favrot et al. (2013).   
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FIG. 8:  Effect of DCPIB fully reversed.  This is the extension of the time-course 
shown in Fig. 13 (D) of Results.  ICl,swell was elicited with 53 M back-filled diazoxide 
(Diaz [in]).  After failure of 500 M H2O2 (dark yellow) to recover ICl,swell following block 
with 15 M Thr101 (red), 10 M DCPIB (cyan) completely blocked the remaining 
current down to initial basal level (~10 pA/pF) in ~10 min.  However, following <10 min 
of washout (WO) with 1T, DCPIB fully reversed and current reached ~25 pA/pF, the 
original current density reached with 10 M Thr101 block near ~65 min, and remained 
for the next ~95 min.  This demonstrated that DCPIB is more efficacious than Thr101; 
nonetheless, unlike Thr101, DCPIB block is fully reversible.        
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FIG. 9:  MTSET blocked ICl,swell and failed to washout.  ICl,swell was activated with 
Diaz [in] and blocked with MTSET prior to attempted washout (WO) in 1T.  Current 
traces (A) and I-V relationships (B) showing break in (blue), activation with Diaz [in] 
(green), block with 110 M MTSET (red), and WO with 1T (dark red).  C.  Time-course 
for the experiment; time of break in denoted by filled blue circle. 
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FIG. 10:  Thr101 blocked ICl,swell only from the outside.  ICl,swell was activated with 
0.8T with 30 M Thr101 back-filled in pipette (Thr101 [in]; see inset) and was blocked 
by 15 M external Thr101 in 0.8T.  Current traces (A) and I-V relationships (B) showing 
break in (blue), activation with 0.8T (green), and block with 15 M Thr101 (red) in 0.8T.  
C. Time-course for the experiment; time of break in denoted by filled blue square.     
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FIG. 11:  Glutamate failed to block ICl,swell.  After activation of ICl,swell, 3 mM 
glutamate (Glu) failed to block the current compared to full block by 10 M DCPIB.  
Current traces (A) and I-V relationships (B) showing break in (blue), activation of 
ICl,swell (green), 3 mM Glu (red), and 10 M DCPIB (dark red).  C. Glu (3 mM) failed to 
block (n = 4, P = 0.490; ns) the activated current (83.1 ± 26.3 pA/pF) compared to 98.5 
± 1.5% block by DCPIB (n = 4, P < 0.001).  D. Time-course for activation, Glu addition, 
and block by DCPIB; time of break in indicated by filled circle (blue).         
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FIG. 12:  CFTR(inh)-172 failed to block ICl,swell.  After activation of ICl,swell with 0.8T, 
20 M CFTR(inh)-172 failed to block the current.  Current traces (A) and I-V 
relationships (B) showing break in (blue), 0.8T-induced activation of ICl,swell (green), 
and 20 M CFTR(inh)-172 (red).  C. CFTR(inh)-172 (20 M) failed to block 80.2 ± 9.0% 
(n = 6, P = 0.079; ns) of the activated current (189.1 ± 39.2 pA/pF).         
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Ebs [in] Affected ICl,swell Block by VAS2870  
VAS2870 (3-Benzyl-7-(2-benzoxazolyl)thio-1,2,3-triazolo(4,5-d)pyrimidine) is a 
cell-permeable NOX inhibitor with an IC50 in the micromolar range widely used in studies 
involving NOX-dependent ROS generation in multiple cell types (Wind et al., 2010; Lange 
et al., 2009; Stielow et al., 2006). When 6 M VAS2870 was superfused following 0.8T-
induced steady-state activation of ICl,swell, VAS2870 failed to block the current during a 15-
min exposure. In contrast, in the same cell, ICl,swell was fully blocked by 15 M Ebs in ~1-
2 min (Appendix, Fig. 13).  However, when the same experiment was repeated with back-
filled Ebs (Ebs [in], 15 M; Appendix, Fig. 14; see inset), 6 M VAS2870 superfusion in 
0.8T gradually but only partially blocked the current in ~25 min (Appendix, Fig. 14). 
This study points to an as yet undefined role for Ebs [in] when cell-permeable 
VAS2870 is superfused.  We previously showed the inability of Ebs [in] (30 M) to block 
ICl,swell from the inside in 0.8T bath solution (Results, Fig. 20). Therefore, Ebs [in] alone 
was not primarily responsible for block shown in Fig. 14 of Appendix.  This then leaves 
VAS2870, the common component of both Fig. 13 and 14 of Appendix, as the key player 
leading to ICl,swell block in the presence of intracellular Ebs (Ebs [in]).  Although the 
mechanism is uncertain, one possibility is that VAS2870 permeated the membrane and 
bound to Ebs [in] generating a product with distinct properties.  Alternatively, the action 
of VAS2870 may have sensitized steps involved in the activation of ICl,swell so that they 
now could be blocked by Ebs [in].  In fact, an off-target interaction of VAS2870 with GSH 
previously was demonstrated by Sun et al. (2012) using mass spectrometric analysis (LC-
ESI-MS).  In each of these examples, we can be assured that back-filled Ebs [in] 
successfully diffused into the cytoplasm, ruling out the possibility that Ebs [in] failed to 
inhibit ICl,swell due to absorption by the inner walls of the borosilicate glass pipette as has 
been suggested (D.E. Logothetis, personal communication).  
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FIG. 13:  VAS2870 failed to block ICl,swell.  After activation of ICl,swell with 0.8T, 6 M 
VAS2870 superfusion failed to block the current compared to 15 M Ebs.  Current 
traces (A) and I-V relationships (B) showing break in (blue), 0.8T-induced activation of 
ICl,swell (green), 6 M VAS2870 (dark red), and 15 M Ebs (red).  C. Time-course for 
the experiment; time of break in denoted by filled blue square.     
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FIG. 14:  VAS2870 blocked ICl,swell in the presence of Ebs [in].  ICl,swell was activated 
with 0.8T with Ebs back-filled in pipette (Ebs [in], 15 M; see inset) and was blocked 
by 6 M external VAS2870 in 0.8T.  Current traces (A) and I-V relationships (B) 
showing break in (blue), activation with 0.8T (green), and slow block with 6 M 
VAS2870 (dark red) in 0.8T.  D. Time-course for the experiment; time of break in 
denoted by filled blue circle.       
 
    
 
103 
 
 
 
 
VITA 
 
Sung Hoon Park (Korean:  박성훈) was born January 1, 1972 in Seoul, S. Korea.  He 
immigrated to the United States with his father and sister (Amy Eui Seong Park) to join 
his mother already living in Los Angeles, CA.  He graduated from Westlake High School 
in Westlake Village, CA in 1990 prior to attending University of California at Los Angeles 
from 1990-1996.  He earned his B.Sc. in Biochemistry in 1996.  While attending a M.Sc. 
program at University of San Francisco from 2007 through 2010, he accepted entrance 
into Medical College of Virginia (MCV) Ph.D. program via the Biomedical Portal in 2010.  
In 2013, Sung was awarded the Ramsey Award, which is awarded to the most 
outstanding doctoral student.  He successfully defended his Ph.D. Defense in July 20, 
2016 at MCV.  His project lead to the discovery of ebselen-para-yne (Ebs-p-yne) which 
demonstrated the highest affinity for the swelling-activated chloride current (ICl,swell) ever 
reported to date.  His project demonstrating complete block of ICl,swell with 5 nM Ebs-p-
yne made the cover page of the yearly Departmental Physiology and Biophysics summer 
retreat booklet.  Several manuscripts are under preparation regarding his research project 
including a first author paper.   
 
 
 
